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ABSTRACT 
Cellular membranes have complex lipid and protein structures that are laterally organized for 
optimized molecular recognition and signal transduction processes.  Knowledge of nanometer-
scale lateral organization and its function is of great importance in the analysis of receptor-based 
signaling.  In model membranes, we studied in detail the chemical and physical factors which 
result in lateral organization of lipids and lipid-mediated protein sequestration into signaling 
domains.  In biological membranes, we mapped the location and follow the dynamic activity of 
specific membrane proteins involved in the immunological response of mast cells.  These studies 
were enabled by our development of advanced imaging methods that provided both high spatial 
resolution and sensitivity to dynamical processes.  Our technical approach was to combine the 
high sensitivity and time resolution of fluorescence imaging with the high lateral resolution of 
atomic force microscopy (AFM).  Simultaneous fluorescence and AFM imaging allows 
correlation of the distribution and dynamic activity of specific biomolecules via fluorescence 
labeling with complete topographic information of the membrane.  Overall, our unique imaging 
capabilities enabled us to examine membrane structure and function with much greater detail than 
was previously possible and thus provide a better understanding of cellular signaling. 
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1. Introduction 
 
Membranes are fundamental components of all cellular organisms.  Not only does the 
membrane enclose each cell as a separate biological entity, but it performs a myriad of critical 
functions to maintain the life of the cell with respect to the “extracellular,” or outside, world.  
Despite the enormous variety of life forms, biological membranes have a common basic structure 
that is composed of a thin (~6.0 nm) film of lipids and proteins.  For many years it was thought 
that the fluid-like behavior of the lipids resulted in a structureless assembly that simply formed 
an impermeable wall.  However, it is now clear that the lipids, in concert with the membrane 
proteins, can be organized into structures that help the cell perform specific functions. 
 
The lipids form a bilayer that incorporates many transmembrane proteins, as well as many 
membrane associated proteins.  Domains of lipids may form within the bilayer due to subtle 
differences in molecular structure.  Many believe that these “lipid rafts” may in turn serve to 
sequester specific groups of proteins that perform specific functions.  Others believe that the 
proteins cluster due to protein-protein interactions and organize the lipids around them.  In any 
case, model membranes were used here to examine the fundamental aspects of lipid domains.  
The lipid bilayer model membranes also served to refine the imaging techniques that were 
subsequently used in biological cell membranes. 
 
One of the most important functions of the membrane is that of “cellular signaling,” the 
process by which “receptor” proteins in the membrane detect specific biomolecules in the 
extracellular environment and trigger a response by the cell.  In collaboration with the Dept. of 
Pathology at the University of New Mexico, Sandia developed advanced imaging techniques to 
map the location of receptor proteins and associated protein partners in the signaling network.  
Specifically, we use atomic force microscopy (AFM), combined with fluorescence labeling, to 
map the location of receptor proteins within the topographical structure of the cytoplasmic 
(interior) side of mast cell membranes.  Mast cells are involved in the adaptable immune 
response that ultimately results in the expression of histamines. 
 
The cell is the ultimate biosensor.  Just a few antigens bound to receptor proteins can induce 
a cascade of cellular processes which can take many years to deduce.  We can learn much about 
biosensing from fundamental studies in cell membrane structure and function.  Moreover, 
medical advances in cancer research and drug therapies will depend to a large extent on a 
molecular-level understanding of cellular signaling at the membrane. 
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2.  Summary of Accomplishments 
 
2.1  Model membrane studies 
 
2.1.1  Domain structure 
 
In the first two publications included for this report, we used simultaneous atomic force 
microscopy (AFM) and confocal fluorescence imaging to examine simple lipid domains in two-
component lipid mixtures.  The first publication (Langmuir 2003, 19, 8358-8363) is focused on 
domain structure and probe portioning.  Although it predates the LDRD, it is included here 
because it explains the detailed experimental techniques and sample preparation protocols that 
were used and refined during the course of the LDRD project. 
 
AFM/fluorescence imaging of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) lipid 
domain structures in 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was performed.  Lipids 
labeled by fluorescent probes either at the headgroups or tailgroups enable domain contrast in 
fluorescence imaging on the basis of partitioning between the gel (DPPC) and disordered liquid 
(DOPC) phases.  The simultaneous acquisition of fluorescence and AFM topographic 
information provides insights on lateral organization that either technique alone would not 
necessarily be able to provide.  Well-defined gel-phase DPPC domains with irregular shapes and 
sizes ranging from 10 nm up to several microns were observed in AFM images on the basis of 
the ~1 nm height difference above the surrounding DOPC fluid-phase.  In the fluorescence 
images, those same (resolvable) domains were observed by the selective partitioning of probe-
labeled lipids for the liquid-phase. 
 
Correlation between the two sets of images revealed that the fluorescent probe lipid 
partitioning was not uniform across the domains, thus potentially distorting domain size and 
shape beyond that imposed by optical resolution.  Furthermore, we found that the fluorescence 
contrast decreases significantly with domain size, such that small domains observed with AFM 
were not observed in fluorescence images despite adequate optical resolution.  We attribute these 
effects in part to broadened partitioning of the probe lipids across the domain boundaries.  
Binding of fluorescent Alexa 488-conjugated cholera toxin B subunits to GM1 gangliosides in 
DPPC domains correlates well with AFM topographic information to the limit of optical 
resolution. However, it also may reveal the presence of dilute GM1 components in the fluid 
phase that have no topographic contrast.  In all cases, the complete correlation of topographic 
and fluorescence images provides evidence that gel-phase domains occur across both leaflets of 
the bilayer. 
 
2.1.2  Local mobility in lipid domains 
 
In the second publication (Biophysical Journal 2005, 89, 1081-1093), fluorescence 
correlation spectroscopy (FCS) was used to examine mobility of labeled probes at specific sites 
in supported bilayers consisting of the same DPPC lipid domains in DOPC.  Those sites were 
mapped beforehand with simultaneous AFM/fluorescence imaging, allowing characterization of 
probe partitioning between gel DPPC and disordered liquid DOPC domains with corresponding 
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topography of domain structure.  We thus examined the relative partitioning and mobility in gel 
and disordered liquid phases for headgroup- and tailgroup-labeled GM1 ganglioside probes, and 
for headgroup- and tailgroup-labeled phospholipid probes.  The four probes were chosen because 
they are fluorescent analogs of naturally occurring lipids and they represent two common 
labeling schemes requiring headgroup and tailgroup modification. Overall, we found that the 
supported model membranes have common attributes in structure and fluidity with unsupported 
vesicles; however, we have also presented unexpected results that suggest possible fluorophore 
effects on probe partitioning, domain heterogeneity, and probe mobility. 
 
Partitioning is an important aspect of lipid “raft” models We saw that the exclusion of 
labeled probes by their unlabeled counterparts in gel domains was indicative of significant 
perturbations in packing and/or lipid interactions, consistent with previous studies on supported 
and unsupported model membranes. For both headgroup- and tailgroup-labeled saturated 
phospholipid analogs, we saw that modifications in either the acyl chain or the head group lead 
to exclusion from the saturated gel domains.  For the GM1 analogs, we found that tail-group 
labeled GM1 was excluded from the gel domains, whereas headgroup-labeled GM1 was not 
excluded. Thus the presence of the fluorescent label on the asialoganglioside head group does 
not interfere with the interactions that allow GM1 to occupy sites in the gel phase DPPC. 
 
Equally important in the lipid raft model of membrane function is the mobility of the lipid 
components inside and outside domains.  Overall, we found that the mobilities of all four probes 
were roughly the same in the DOPC fluid phase.  Thus we found no glaring difference in fluid 
phase mobility due to the location of the head or tail group labeling.  Both tailgroup-labeled 
GM1and unmodified GM1 were shown to slow down by at least a factor of six upon binding to 
cholera toxin B (CTX-B) fragments, which most likely indicates clustering induced by the 
pentameric CTX-B. Mobility of the unbound GM1 analogs was severely attenuated in the gel 
phase DPPC. This was definitely the case for the headgroup-labeled GM1, indicating a tight 
packing by the surrounding DPPC lipids.  Furthermore, mobility appeared to be restricted around 
the domain boundaries.  The mobility in DPPC was also restricted for tailgroup-labeled GM1, 
however evidence was presented for increased mobility in submicron domains that may be due to 
DPPC packing heterogeneities.  Mobility around the domain boundaries was higher, resembling, 
for the most part, that in the fluid phase.  
 
This trend of increasing mobility in and around the submicron DPPC domains was 
remarkably prevalent in the tailgroup-labeled and headgroup-labeled phospholipid analogs.  For 
these probes there appeared to be little reduction in the lateral diffusion in the submicron DPPC 
domains relative to the DOPC regions.  The results for submicron domains may be relevant to 
mobility in sphingolipid-cholesterol domains in biological membranes, where domain sizes are 
believed to less than 100 nm.  Thus its appears that those lipids such as headgroup-labeled GM1 
and unmodified GM1 that partition into the DPPC domains do not disrupt the dense packing and 
thus are rendered immobile.  Whereas those lipids that are excluded on the basis of disrupting the 
gel packing and/or lipid-lipid interactions may have greater mobility. 
 
We were able to show that FCS can reveal heterogeneities in supported lipid bilayers.  The 
phospholipid probes not only exhibited a perplexing mobility in submicron DPPC domains, but 
also required two-component fits to the FCS curves in the fluid DOPC phase. The slow 
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component could be due to variety of factors including substrate interactions and membrane 
heterogeneities. However, it could also be due to local distortion of the molecule and 
surrounding matrix lipids by the tendency of fluorophores to seek polar regions of the 
membrane. This effect may also be responsible for exclusion of the probes from close-packed gel 
domains. In any case, it is clear that the phospholipid probes, as well as other labeled 
phospholipid lipids using different fluorophores, are not ideal for the modeling of partitioning 
and mobility in membranes. They do, however, illustrate that lipid components and lipid-protein 
complexes in biological membranes could move rapidly in and out of raft domains as needed. 
 
 
2.2  Signaling domains in mast cell membranes 
 
Immunogold labeling and transmission electron microscopic (TEM) imaging work at UNM 
of endogenous proteins in the cytoplasmic face of mast cell membranes, including the abundant 
IgE receptor (FcεRI) and its signaling partners, has revealed that most proteins in native 
membranes are dispersed prior to stimulus.  Since the cell membrane is adaptable and capable of 
dynamic reorganization, the FcεRI can coalesce within minutes of activation into patches as 
large as 200-400 nm in diameter.  Because these sites of receptor aggregation accumulate many 
signaling proteins, they are presumed to be sites of active signaling.  The signaling patches 
typically occupy "dark" membrane regions that show enhanced labeling with osmium, indicating 
high levels of double bond-containing lipids and/or cholesterol, and are frequently bordered by 
clathrin-coated pits.  It was of great interest, therefore, to determine if the signaling patches are 
indeed distinct topographic features in mast cell membranes. 
 
Thus we used AFM/fluorescence imaging to examine the topography of the cytoplasmic 
face of plasma membrane sheets stripped from tumor mast cells (RBL-2H3).  This work is 
included here as the third publication (Biophysical Journal 2006, 90, 2404-2413).  AFM has 
been used extensively to characterize biological samples because it can be routinely performed in 
natural fluid environments, which is a clear advantage over vacuum conditions imposed by the 
TEM.  A key feature of the work was the ability to correlate membrane topographic features with 
the locations of fluorescently tagged proteins and lipids, through simultaneous acquisition of 
AFM and confocal fluorescence images. 
 
Our results revealed the presence of distinct membrane features (raised domains) that have 
the ability to concentrate numerous membrane molecules, including cross-linked receptors, 
gangliosides and clathrin.  The principal effect of cell activation is to cause the reorganization of 
membrane components into larger domains. Based on composition, we concluded that the raised 
domains seen by AFM correspond to the dark patches observed in TEM images of signaling 
domains that also localize the immunoreceptor FcεRI, at least 10 associated signaling molecules, 
and also molecules involved in coated pit assembly to dark regions of activated mast cell 
membrane.  Thus we suggested that they represent areas that concentrate transmembrane and 
peripheral membrane proteins, and that their bulky cytoplasmic tails and associated binding 
partners contribute to the height.  Finally, we showed by TEM that the cholesterol marker PFO 
preferentially binds darkened membranes and by AFM that cholesterol extraction causes a large 
reduction in height of the raised domains. These complementary results indicate that cholesterol 
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contributes significantly to the formation or stability of the raised domains. The mechanism is 
not known with certainty.  
 
When present, a fibrous meshwork appeared to link adjacent raised domains, suggesting a 
role for the cortical cytoskeleton in organizing these prominent features of the plasma membrane 
landscape.  The apparent relationship of the raised domains to the cytoskeleton is of particular 
interest. Elsewhere, previous diffusion experiments, such as fluorescence recovery after 
photobleaching data and single particle tracking data, have led to models that consider roles for 
cytoskeletal “fences” or “corrals” and anchored protein “pickets” in the temporary, dynamic 
confinement of membrane proteins and lipids and also in the formation of less mobile 
macromolecular complexes during signaling.  However, particularly for particles linked to lipids, 
it has never been clear why interactions of the cytoskeleton with components of the inner leaflet 
of the membrane bilayer would regulate mobility in the outer leaflet of the bilayer.  The AFM 
images acquired in our work showed cytoskeletal elements surrounding and connecting the 
raised domains.  These images thus raise the possibility that the cortical cytoskeleton may 
determine the stability and characteristics of membrane domains, that in turn may determine the 
ability of proteins (and lipids) to access and escape from these specialized regions. 
 
Overall the data suggested that signaling and endocytosis occur in mast cells from raised 
membrane regions that depend on cholesterol for their integrity and may be organized in specific 
relationship with the cortical cytoskeleton.  AFM/fluorescence imaging of the inner membrane 
landscape revealed levels of topographical complexity that are not addressed either in the well-
mixed lipid and protein models of membrane structure, or in progressively more complex models 
developed over the subsequent decades that incorporate concepts of compositional and 
functional heterogeneity within the membrane bilayer and between the membrane and the 
cytoskeleton. 
Domain Structure in Model Membrane Bilayers
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Simultaneous atomic force microscope (AFM) and submicron confocal fluorescence imaging of
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) lipid domain structures in 1,2-dioleoyl-sn-glycero-
3-phosphocholine (DOPC) is presented. Lipids labeled by fluorescent probes either at the headgroups or
tailgroups enable domain contrast in fluorescence imaging on the basis of partitioning between the gel
(DPPC) and disordered liquid (DOPC) phases. However, correlation with AFM topographic information
reveals that they do not always faithfully report exact gel domain size or shape. Furthermore, we find that
the fluorescence contrast decreases significantly with domain size, such that small domains observed with
AFM are not observed in fluorescence images despite adequate optical resolution. We attribute these
effects in part to broadened partitioning of the probe lipids across the domain boundaries. Binding of
fluorescent Alexa 488-conjugated cholera toxin B subunits to GM1 gangliosides in DPPC domains correlates
well with AFM topographic information to the limit of optical resolution. However, it also may reveal the
presence of dilute GM1 components in the fluid phase that have no topographic contrast. In all cases, the
complete correlation of topographic and fluorescence images provides evidence that gel-phase domains
occur across both leaflets of the bilayer.
1. Introduction
Supported lipid bilayers have been studied extensively
as models for biological membranes1-3 because of the
ease by which they can be characterized by numerous
techniques, particularly imaging microscopies. A 1-2 nm
layer of water1 between the solid support (usually glass
or mica) and the lipids allows freedom of movement of
both leaflets, thus preserving integrity of the bilayer as
a membrane to a good approximation. Recently, there has
been considerable activity in the study of distinct phase
domains in multicomponent lipid bilayers and monolayers,
both supported4-12 and unsupported,13-18 as models for
“lipid rafts”, believed to be important in cellular signaling
processes.19-24 Briefly, transmembrane and membrane-
associated proteins involved in cellular signaling often
have been shown to be components of densely packed,
detergent-resistant domains of saturated lipids within the
membrane.19,21,22 The role of these “rafts” is thought to be
one of binding or sequestering specific proteins for
specialized functions within the membrane.19-24 This
association of proteins with lipid domains may in turn be
mediated by much smaller “shells” of lipids surrounding
the protein.25 Thus, many studies of lipid domains in model
systems have focused on phase separation within mul-
ticomponent lipid mixtures, on the basis of headgroup
interactions and/or acyl chain structure, and the subse-
quent partitioning of protein-binding glycosphingolipids
between the phases.
Domain structure in bilayer and monolayer assemblies
has been characterized by numerous fluorescence mi-
croscopy methods including far-field14,15,17,26 and near-field
imaging,27-29 fluorescence recovery after photobleach-
ing,10,13 and fluorescence quenching.16,18 Indeed, these
techniques have been useful for domain studies on cellular
membranes as well.19,30-34 Fluorescent labels are usually
placed on specific lipids that subsequently partition
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between the gel-phase (or liquid-ordered) raft domains
and the liquid-disordered domains, although labeling of
interacting proteins is also used. It is difficult to minimize
the influence of the label on the lipid interaction with its
neighbors; thus, the location of the label, on the headgroup
or acyl chains, as well as acyl chain length,18 can lead to
significant differences in partitioning.
Atomic force microscopy (AFM) has been used to image
organizational structure in supported lipid monolayers
and the top leaflet of bilayers on the basis of topographic
height differences between gel-phase and liquid-disor-
dered domains.4,5,7,8,12 The origin of this height difference
most likely arises because the “taller” gel-phase domains
of saturated acyl chains are more tightly packed relative
to liquid disordered domains (usually lipids with unsat-
urated acyl chains); thus, they occupy a smaller area per
molecule and are oriented more normal to the substrate.4
Microdomains of glycosphingolipids, such as GM1, have
been resolved on the basis of their large headgroups.5,7,8,12
Like fluorescence imaging, AFM can be routinely per-
formed with the model membranes in fluid environments,
thus allowing lipid mobility and full interaction with
solutes such as proteins. It has also been well-established
that AFM can provide undistorted molecular-scale lateral
(<2 nm) and vertical (<0.1 nm) resolution of compliant
membrane structures, due in large part to sensitive force
feedback detection (<1 nN) and sharp probes (<20 nm tip
radius).35-37 As with all scanning probes, AFM is primarily
useful for imaging relatively “static” features that are not
rapidly diffusing or changing shape.
The ability to correlate information gathered from
fluorescence imaging on supported membranes in a fluid
environment with detailed lateral structures mapped out
with AFM would be highly advantageous. In a step toward
this goal, the utility of performing simultaneous AFM and
submicron confocal fluorescence imaging is demonstrated
on lipid bilayers consisting of 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine (DPPC) gel-phase domains in a 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) liquidphase.
It is shown that since the fluorescent labels are subject
to partitioning between the gel (DPPC) and disordered
(DOPC) lipid phases, they do not always faithfully report
exact gel domain size or shape. Furthermore, the fluo-
rescence contrast decreases significantly with domain size,
such that small domains observed with AFM are not
observed in fluorescence images despite adequate optical
resolution. Fluorescent markers do, however, reveal the
presence of dilute components in the fluid phase that have
no topographic contrast.
2. Materials and Methods
2.1. Lipids and Protein. 1,2-Dipalmitoyl-sn-glycero-3-
phosphocholine, 1,2-dioleoyl-sn-glycero-3-phosphocholine, and
GM1 ovine brain ganglioside were purchased from Avanti Polar
Lipids and used without further purification. N-(4,4-Difluoro-
5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)-1,2-di-
palmitoyl-sn-glycero-3-phosphoethanolamine (BODIPY-DPPE,
also known as BODIPY-DHPE), N-(4,4-difluoro-5,7-dimethyl-
4-bora-3a,4a-diaza-s-indacene-3-propionyl)-C5-ganglioside GM1
(BODIPY-C5-GM1), and Alexa 488-conjugated cholera toxin B
subunit (Alexa 488-CTX-B) were purchased from Molecular
Probes and used without purification unless otherwise indicated.
2.2. Supported Bilayers. Lipid bilayers are formed on glass
coverslips by the method of vesicle fusion.2,3 Single unilamellar
vesicles are prepared by first dissolving the lipids in chloroform,
followed by rotary evaporation of the solvent and drying for over
12 h under high vacuum. The lipids are resuspended by adding
phosphate-buffered saline (PBS) buffer (100 mM NaCl, 40 mM
sodium phosphate, pH 7.4) and vortexing, followed by degassing
with nitrogen. The mixtures are tip-sonicated for 4 min cycles
over 20 min while being cooled with an ice bath. The resulting
vesicle suspensions are centrifuged at 15000 rpm, with the
supernatant filtered through a 0.2 ím syringe filter. Dynamic
light scattering characterization (Protein Solutions) usually
indicates vesicles diameters are in the range of 50-100 nm.
Glass coverslips (0.13-0.17 mm thickness) are cleaned in (7:3)
H2SO4/H2O2, (caution: this is potentially explosive when reacting
with organics), rinsed thoroughly in distilled and ultrapure water
(Barnstead Nanopure), and stored under ultrapure water (18
M¿âcm). Just prior to use, the coverslips are dried under a stream
of pure, dry nitrogen and mounted in a Leiden coverslip dish
(Harvard Apparatus). The 3 mM vesicle solution is pipetted
onto the coverslip and diluted (1:5) with imaging PBS buffer
(150 mM NaCl, 50 mM sodium phosphate, 1. 5 mM NaN3, pH
7.4). After 2 h of incubation at 60 °C, followed by cooling to room
temperature, the lipid bilayer is rinsed thoroughly with imaging
PBS buffer and mounted on the microscope. When required,
incubation of the lipid bilayers with Alexa 488-CTX-B stock
solution (10 íg/mL, in imaging PBS buffer) is performed for 1-2
min, followed by thorough rinsing with imaging PBS buffer. Prior
to use, the stock solution was passed through chromatography
columns (Sephadex G25 or Bio Rad Micro Bio Spin 6) to reduce
the amount of unconjugated Alexa 488.
2.3. AFM and Fluorescence Microscopy. The experimental
apparatus for obtaining simultaneous AFM and fluorescence
images of lipid bilayers is shown schematically (not to scale) in
Figure 1. The instrument is based on an inverted microscope
(Olympus IX-70) platform modified to accommodate an AFM
scan head (Digital Instruments Bioscope G scanner). The
microscope is mounted on a vibration isolation air table that is
also acoustically- and light-isolated. The liquid cell (coverslip
dish) is mounted on a flat-plate XY scanner (Nanonics) that allows
full optical access below and AFM access above the sample.
Excitation light from a continuous 488 nm Ar+ laser (on a separate
table) is coupled into a single-mode optical fiber that ports the
light to the microscope table and also serves as a spatial filter.
A fiber coupler (FC1 in Figure 1) then forms a collimated Gaussian
beam that reflects off a dichroic mirror (Chroma Q495LP) and
(31) Hwang, J.; Gheber, L. A.; Margolis, L.; Edidin, M. Biophys. J.
1998, 74, 2184.
(32) Varma, R.; Mayor, S. Nature 1998, 394, 798.
(33) Kenworthy, A. K.; Petranova, N.; Edidin, M. Mol. Biol. Cell 2000,
11, 1645.
(34) Schu¨tz, G. J.; Sonnleitner, M.; Schindler, H. J. Fluoresc. 2001,
11, 177.
(35) Mu¨ller, D. J.; Fotiadis, D.; Engel, A. FEBS Lett. 1998, 430, 105.
(36) Mu¨ller, D. J.; Heymann, J. B.; Oesterhelt, F.; Mo¨ller, C.; Gaub,
H.; Bu¨ldt, G.; Engel, A. Biochim. Biophys. Acta 2000, 1460, 27.
(37) Czajkowsky, D. M.; Shao, Z. FEBS Lett. 1998, 430, 51.
Figure 1. Schematic (not to scale) of experimental apparatus
for acquiring AFM and fluorescence images. See text for details.
FC1 and FC2 are fiber couplers for excitation light and
fluorescence emission, respectively. APD is an avalanche
photodiode. The scanning stage is mounted on an inverted
microscope stage (not shown).
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fills the back plane of a 100 (1.3 NA) oil immersion objective.
The objective focuses the light (<2 íW) to a 250-300 nm spot
size spatially coincident on the sample with the pyramidal tip
on the end of the AFM cantilever, as can been seen through the
microscope eyepiece. This alignment remains fixed as the sample
is scanned. Epi-fluorscence emission is collected by the same
objective and passes through the dichroic mirror, through two
notch filters (488 and 670 nm, Kaiser), and through a 500-580
nm band-pass filter (Chroma HQ 540/80). The fluorescence is
then spatially filtered in a confocal manner by coupling (FC2 in
Figure 1) into a 50 ím diameter core multimode fiber connected
to an avalanche photodiode detector (EG&G SPCM-AQR).
A single controller (RHK Technology) is used for sample
scanning, AFM feedback, and photon counting of the fluorescence,
thus providing simultaneous topographic and fluorescence im-
ages. Fluorescence background count rates for blank substrates
were less than 1 kHz. A slight nanometer-scale offset between
the two images is possible due the alignment of the laser focus
on the AFM lever. All the AFM data presented here were acquired
with levers (Olympus TR400-PSA; nominal force constant of 0.08
N/M) in contact mode under a feedback load e 0.2 nN. Force
calibration was checked with the thermal power spectrum
method.38 The XY scanner plate was calibrated with a 463 nm
square grid grating (Ted Pella, Inc.), and the AFM head was
calibrated in Z with known 25.5 nm steps (TGZ01, NT-MDT
Mikromasch).
3. Results and Discussion
Lipid bilayers were created from a 3:1 molar mixture
of DOPC/DPPC and various fluorescent probes. In all
cases, the vesicle fusion process, which occurred above
the gel-fluid transition temperature of DPPC (41 °C),
produced bilayers without apparent defects. Due to the
allotment of least 1 h for temperature equilibration of the
cantilevers in the coverslip dish, there was ample time for
the stabilization of the gel/fluid phases.11 Thus, the images
shown below were static for the period of several hours.
In Figure 2 are shown 3.0 ím AFM and fluorescence
images acquired simultaneously of a DOPC/DPPC (3:1)
bilayer with 0.5% BODIPY-DPPE. The gel domains of
DPPC are readily observed in the AFM images (Figure
2A) on the basis of the 1.1 ( 0.2 nm height above the
DOPC fluid phase, consistent with previous results.4,5,7,8,12
The DPPC domains have irregular shapes and a size
distribution ranging from 10 nm to >1 ím. In the
corresponding fluorescence image (Figure 2B), the do-
mains are darker than the surrounding DOPC, thus
revealing that the BODIPY-DPPE is excluded from the
DPPC domains. Due in part to the 300 nm limit in confocal
optical resolution, the domain boundaries are blurred in
the fluorescence image and thus lack the detail observed
in the topographic image. Also, by having both AFM and
fluorescence images, one can readily observe that in the
fluorescence image larger domains are darker that the
smaller ones.
The BODIPY label is situated on the DPPE headgroup,
thus leaving the saturated acyl chains unperturbed
relative to the DOPC/DPPC matrix. Since BODIPY-DPPE
and DPPC have identical saturated acyl chains, it is
surprising that the probe lipid tends to be excluded from
the tightly packed DPPC domains. It is thus perhaps due
to headgroup interactions that it goes into the DOPC fluid
phase. Similar behavior was observed for headgroup-
labeled DPPE probes in Langmuir-Blodgett monolay-
ers.9,10,26 The BODIPY-DPPE is not completely excluded
from the gel domains, however, as can be seen from the
fluorescence intensity profile in Figure 2C. The lowest
count rates, corresponding to the darkest regions, still
exceed the background count rate of 1 kHz by several
orders of magnitude. For the most part, the gradual slope
of the fluorescence line profile relative to the sharp domain
boundaries delineated in the topograph line profile (also
shown in Figure 2C) is due to the limited (300 nm) optical
resolution. However, there is a small, additional broaden-
ing that indicates that the BODIPY-DPPE partitioning is
not sharp across the boundary. This gradient of the
BODIPY-DPPE concentration associated with the domain
boundary is more obvious in Figure 3, where AFM and
fluorescence images are shown for a very large DPPC
domain in the same sample.
The fluorescent line profile in Figure 3C clearly indicates
that the relative exclusion of the BODIPY-DPPE from
the large DPPC domain increases with distance from the
domain boundary to the center of the domain. For the(38) Hutter, J. L.; Bechhoefer, J. Rev. Sci. Instrum. 1993, 64, 1868.
Figure 2. 3.0 ím scan featuring topographic (A) and fluo-
rescence (B) images of a 3:1 DOPC/DPPC bilayer, with 0.5%
BODIPY-DPPE, on glass (scale bar ) 500 nm). The height of
the DPPC domains in A is 1.1 ( 0.2 nm. In the fluorescence
image (B), the dark regions are due to the exclusion of the
headgroup-labeled BODIPY-DPPE from the DPPC domains.
The smaller domains are not as dark as the largest, indicating
less exclusion. In C, a fluorescence line profile (solid) and
corresponding topographic line profile (dotted) are plotted for
the largest domain. The left boundary of the domain is marked
by the dashed line.
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sake of comparison with previous results, one can estimate
a maximum relative partition coefficient R ) (IG/(IG+IL)),
where IG is the intensity at the center of the domain and
IL is the intensity well outside the domain. For Figure 3C,
R = 0.25, whereas, for Figure 2C, R = 0.37. For fluorescein
headgroup-labeled DPPE, a coefficient R ) 0.14 has been
measured for partitioning into large (>1.0 ím) sphingo-
myelin-chloesterol domains in DOPC.10 Thus, the R value
for Figure 3C is comparable, despite the change in lipids
and probe. The larger R value for the smaller domain in
Figure 2C points to an important aspect of the simulta-
neous AFM and fluorescence images presented in Figures
2 and 3: the smallest domains exhibit the weakest
fluorescence contrast, not only because they are more
difficult to optically resolve but also because the relative
partition coefficient of the probe lipid is approaching 0.5
(i.e., uniform coverage). The apparent gradient in the
BODIPY-DPPE probe concentration across the domain
boundaries also has the potential to mask irregular domain
shapes (possibly indicating solid-phase domains39) and
make them appear more circular (indicating more fluidlike
domains). Furthermore, a very important question arises
from these observations: is the boundary between the
DOPC fluid-phase region and DPPC gel-phase region
really as sharp as that indicated by the AFM topographic
data? A slight mixing of the two components across the
domain boundary would help to explain the partitoning
results and also make possible an initial decrease of the
BODIPY-DPPE concentration on the “DOPC side” of the
topographically defined boundary.
The glycosphingolipid GM1 has been shown in several
fluorescence9,10,17,18,26 and AFM studies5,7,8,12 to partition
into the gel-phase domains. It is even thought to be
immiscible in DOPC.26 However, when the acyl chains
are modified with a fluorescent probe, as is the case with
BODIPY-C5-GM1, one can see from the 6.0 ím images
presented in Figure 4 that the tailgroup-labeled GM1 is
predominantly excluded from the DPPC gel-phase and
resides in the DOPC matrix. This observation is consistent
with previous bilayer domain studies using tailgroup-
labeled sphingolipids.16,17 The exclusion of the tailgroup-
labeled BODIPY-C5-GM1 from the gel phase is most likely
due to the larger molecular area induced by steric
interference between the probe and the longer acyl
chains.18 From the fluorescence line profile (Figure 4C),
the BODIPY-C5-GM1 partition coefficient R = 0.25 at the
center of the domain, where it is fairly flat over at least
1.5 ím. Just as discussed above with the headgroup-
labeled DPPE, we see in Figure 4B,C a more gradual
partitioning of the tailgroup-labeled GM1 between the
two phases than is dictated by the phase boundary or the
300 nm optical resolution. Finally, as expected for AFM
imaging in a fluid phase, the large GM1 headgroups are
completely unresolved and no aggregation of the GM1 is
observed in the DOPC regions. However, the DPPC
domains in Figure 4A are now 0.8 ( 0.1 nm higher than
the surrounding DOPC, a slightly smaller difference than
that (1.1 ( 0.2 nm) observed in Figures 2 and 3 in the
absence of GM1, and which may reflect the presence of
GM1.
An important issue that is mentioned in numerous
studies of lateral structure in model lipid bilayers is the
superposition of domains between the bilayer leaflets; i.e.,
do the domains span both leaflets of the bilayer? Much
evidence has been presented, particularly via fluorescence
techniques,9,13,14,17 that this is indeed the case. The
evidence resides in that no overlapping of different-sized
domains is observed, nor are there “gray” features that
derive from emission from only one leaflet and thus are
half the intensity of emission from bilayer domains. These
observations are also supported by the fluorescence images
obtained in the present work. However, as discussed above,
one notes that domains in Figures 2 and 3 become less
and less dark with shrinking size due in part to the
diminished exclusion of the probe lipid. Thus, the gray
criteria would lead to erroneous conclusions for small
domains (<1 ím) relative to large domains (>1 ím). The
(39) Veatch, S. L.; Keller, S. L. Phys. Rev. Lett. 2002, 89, 268101.
Figure 3. 3.0 ím scan featuring topographic (A) and fluo-
rescence (B) images of a 3:1 DOPC/DPPC bilayer, with 0.5%
BODIPY-DPPE, on glass (scale bar ) 500 nm). The height of
the DPPC domains in A is 1.1 ( 0.2 nm. The large domain is
likely formed by coalescence of smaller domains, as evidenced
by residual pockets of DOPC. In the fluorescence image (B), the
dark region is due to the exclusion of the headgroup-labeled
BODIPY-DPPE from the DPPC domains. It does not appear to
be excluded from the small domains, although optical resolution
is limiting detection of the smallest. In C, a fluorescence line
profile (solid) and corresponding topographic line profile (dotted)
are plotted for the large domain. The left boundary of the domain
is marked by the dashed line. Overlaid on this dashed line is
a diffraction-limited (300 nm) line profile (thin solid) to show
that the fluorescence line profile is considerably broadened
beyond the diffraction limit.
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question of leaflet superposition of domains is more easily
verified here than in previous studies because there is
always a correlation between the AFM and fluorescence
images. For each domain in the fluorescence there is a
corresponding feature in the AFM topography. If there
was poor registry between leaflets, then one would expect
to see light or dark regions in the fluorescence images
without topographic correlation.
Alexa 488-CTX-B binds to GM1 receptors and thus is
an effective way to detect or “stain” unlabeled GM1 in the
upper leaflet.9,10,26 In Figure 5, the simultaneous AFM
and fluorescence images are shown for a (3:1) DOPC/DPPC
bilayer containing 1% GM1 that is subsequently incubated
with Alexa 488-CTX-B. As expected from previous re-
sults,9,10,26 the unlabeled GM1 is now readily incorporated
into the DPPC domains seen in the AFM image (Figure
5A) and which appear bright in the fluorescence image
(Figure 5B) due to the presence of GM1-bound Alexa 488-
CTX-B. Due to the toxin binding to GM1, the DPPC
domains in the AFM image now have a height of 3.2 ( 0.3
nm relative to the DOPC matrix. High-resolution images
(not shown) of the DPPC domains reveal a uniform
coverage of close-packed 7 nm features that correspond
to CTX-B pentamers.37 The fluorescence image shown in
Figure 5B has distinct features not seen in the other data
(Figures 2-4). The domains are uniformly bright and do
not exhibit a fading toward the domain boundary. Thus,
the small domains (<1 ím) are as bright as the larger
domains, and the sharpness of the fluorescence features
as seen in the line profile (Figure 5C) is limited only by
the 300 nm optical resolution of the domain boundaries
and not by partitioning of the GM1 to the DOPC fluid
phase. Thus, it appears that the unlabeled GM1 is
Figure 4. 6.0 ím scan featuring topographic (A) and fluo-
rescence (B) images of a 3:1 DOPC/DPPC bilayer, with 0.25%
BODIPY-GM1, on glass (scale bar ) 1.0 ím). The height of the
DPPC domain in A is 0.8 ( 0.1 nm. In the fluorescence image
(B), the dark region is due to the exclusion of the tailgroup-
labeled GM1 from the DPPC domains. In C, a fluorescence line
profile (solid) and corresponding topographic line profile (dotted)
are plotted. The left and right boundary of the domain is marked
by the dashed lines.
Figure 5. 5.0 ím scan featuring topographic (A) and fluo-
rescence (B) images of a 3:1 DOPC/DPPC bilayer, with Alexa
488-CTX-B bound to 1.0% unlabeled GM1, on glass (scale bar
) 1.0 ím). The combined height of the DPPC domains and
bound CTX-B in A is 3.2 ( 0.3 nm. In the fluorescence image
(B), the bright regions are due to the Alexa 488-labeled CTX-B
bound to the DPPC domains. In C, a fluorescence line profile
(solid) and corresponding topographic line profile (dotted) are
plotted. The fluorescence line shapes of the two prominent
features are diffraction-limited (fwhm = 300 nm).
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predominantly restricted to the DPPC gel phase and is
uniformly distributed in it. However, there is a much larger
than expected fluorescence background in the liquid DOPC
phase. It may be attributed in part to unconjugated Alexa
488 probe, although the Alexa 488-CTX-B stock solution
was passed through separation columns in an attempt to
remove unconjugated probe. The background may also be
attributed to a small component of the GM1 lipids (purified
from ovine brain) that have acyl chains that could be
excluded from the gel phase. Further studies on other
lipidmixtures, such as DOPC/sphingomyelin/cholesterol,10
where GM1 was shown to have a partition factor R = 0.95
for the gel-phase, are required before a conclusion can be
drawn. In any case, an important point to note here is
that fluorescence data have the potential to reveal the
presence of GM1 in the fluid phase that would not be
ordinarily detected by AFM.
4. Conclusions
Independent fluorescence and AFM imaging methods
have been successfully used in the past to investigate
domain formation in multicomponent lipid bilayers. It has
been demonstrated here, for 3:1 DOPC/DPPC bilayers
supported on glass, that the simultaneous acquisition of
fluorescence and AFM topographic information provides
insights on lateral organization that either technique alone
would not necessarily be able to provide. Well-defined gel-
phase DPPC domains with irregular shapes and sizes
ranging from 10 nm up to several micrometers were
observed in AFM images on the basis of the 1 nm height
difference above the surrounding DOPC fluid-phase. In
the fluorescence images, those same (resolvable) domains
wereobservedbytheselectivepartitioningofprobe-labeled
lipids for the liquid phase.
Correlation between the two sets of images revealed
that the fluorescent probe lipid partitioning was not
uniform across the domains, thus potentially distorting
domain size and shape beyond that imposed by optical
resolution. Factors that govern probe lipid partitioning
across domain boundaries need to be studied in more
detail. Models that incorporate both chemical and physical
factors that not only lead to domain formation but also
relative partitioning of tailgroup- and headgroup-labeled
probes are required. This is complicated by the unknown
lipid composition at these boundaries, despite the abrupt
height difference in the bilayer topography. A more precise
understanding of the topographical height difference
between gel and fluid domains is also necessary in order
to understand the multicomponent composition at the
domain boundaries.
The results presented here also possibly indicate that
the glycosphingolipid GM1 may not reside exclusively in
the densely packed gel-phase domains as could be
construed from AFM, but may have some finite concen-
tration in the fluid phase as detected by fluorescence from
bound, labeled protein. Future studies of lateral structure
and signaling processes in model membranes and har-
vested biological membranes will surely benefit from
combined techniques such as that presented here. More-
over, this work provides a basis and motivation for
improvements in optical resolution provided by near-field
enhanced fluorescence excitation at metallic AFM probe
tips.40,41
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Local Mobility in Lipid Domains of Supported Bilayers Characterized by
Atomic Force Microscopy and Fluorescence Correlation Spectroscopy
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ABSTRACT Fluorescence correlation spectroscopy (FCS) is used to examine mobility of labeled probes at speciﬁc sites in
supported bilayers consisting of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) lipid domains in 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC). Thosesitesaremappedbeforehandwith simultaneousatomic forcemicroscopyandsubmicron confocal
ﬂuorescence imaging, allowing characterization of probepartitioning betweengelDPPCanddisordered liquidDOPCdomainswith
corresponding topography of domain structure. We thus examine the relative partitioning and mobility in gel and disordered liquid
phases for headgroup- and tailgroup-labeled GM1 ganglioside probes and for headgroup- and tailgroup-labeled phospholipid
probes. For the GM1 probes, large differences in mobility between ﬂuid and gel domains are observed; whereas unexpected
mobility is observed in submicron gel domains for the phospholipid probes. We attribute the latter to domain heterogeneities that
could be induced by the probe. Furthermore, ﬁts to the FCS data for the phospholipid probes in the DOPC ﬂuid phase require two
components (fast and slow). Although proximity to the glass substrate may be a factor, local distortion of the probe by the
ﬂuorophore could also be important. Overall, we observe nonideal aspects of phospholipid probemobility and partitioning thatmay
not be restricted to supported bilayers.
INTRODUCTION
The lateral organization and dynamics of lipids and proteins
in membranes is critical to many cellular processes. Thus
there has been considerable interest in the study of membrane
microdomains (‘‘lipid rafts’’) to determine their size, location,
and function in membrane organization (1–3). Studies of
domains in cellular membranes have relied heavily on fluo-
rescence-based imaging of protein colocalization and lipid
structure (4–6) and fluorescence-based dynamical studies of
lipid probes and labeled proteins. Concerning dynamics, it is
widely held that translational diffusion rates reflect not only the
intrinsic mobility of membrane constituents but also the local
structure of the membrane. Thus we have seen the application
of a variety of techniques that offer considerable insight into
diffusion processes in cellular membranes at various length
scales. These include fluorescence recovery after photobleach-
ing (FRAP) (7,8), single particle tracking (SPT) (7,9,10), and
fluorescence correlation spectroscopy (FCS). Applications of
FCS to diffusion in membranes have been discussed com-
prehensively in the literature (11–15). Since the sensitivity of
time-dependent statistical analysis of fluorescence intensity in
FCS scales inversely with detection volume and probe con-
centration, it is an excellent tool to complement low-light-level
confocal fluorescence imaging of membranes.
Both fluorescence-based imaging and dynamics have also
been essential to the analysis of the structure of lipid domains
and component mobility in model membranes. Model
membrane studies offer the ability to characterize phase
separation, due to headgroup interactions and/or acyl chain
structure, of gel or liquid-ordered domains (‘‘rafts’’) within
multicomponent lipid mixtures, on the basis of subsequent
partitioning of lipid probes or protein-binding glycosphingo-
lipids between the phases (16–19). By partitioning, we refer
to the process by which probes go preferentially into one
domain but can be observed in both. It has been shown using
FCS (20,21), FRAP (22,23), and SPT (24,25) that the two-
dimensional lateral diffusion coefficient of most probes
is strongly dependent on the lipid packing of the domains:
;1–10 3 108 cm2/s in liquid-disordered phases to essen-
tially immobile (,1011 cm2/s) in gel phases.
Since dynamical processes are dependent on the local
membrane structure as well as local molecular interactions, it
would be advantageous to directly correlate dynamics in-
formation with detailed lateral dimensions and topography
mapped out with atomic force microscopy (AFM). AFM has
been successfully used to image domain structure in sup-
ported lipid monolayers and bilayers in fluid environments on
the basis of topographic height differences between gel-
phase, liquid-ordered, and liquid-disordered domains (23,26–
28). Recently, simultaneous AFM and confocal fluorescence
imaging was used to examine the partitioning of lipid probes
between fluid and gel domain boundaries mapped with 1 nm
lateral resolution (28). We now present FCS measurements of
diffusion coefficients of lipid and glycolipid probes at pre-
cisely defined locations on supported bilayers mapped out
with the same technique. The resolution is limited only by the
spot size (;400 nm) of the laser beam on the sample. Of
particular interest is the boundary region between domains.
Also, it has been shown that the location of the fluorescent
probe (e.g., headgroup versus tailgroup) on the lipid molecule
has significant impact on partitioning between domains
(18,19,28). Since partitioning and lateral diffusion are both
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expected to be sensitive to local molecular interactions, it is of
interest to determine if the location of the fluorescent probe
influences the lateral diffusion as well. Thus, we examine the
relative partitioning and diffusion coefficients in gel (DPPC)
and disordered liquid (DOPC) phases and boundary regions
for both headgroup- and tailgroup-labeled GM1 ganglioside
as well as for headgroup- and tailgroup-labeled phospholipid
analogs of DPPC. Since GM1 selectively binds cholera toxin
B (CTX-B) fragments, we are also able to examine the effects
of protein binding on GM1 mobility in the fluid DOPC phase.
Numerous studies of supported bilayers in fluid environ-
ments have shown that domain structure and freedom of
movement of lipid components are, for the most part, pre-
served relative to unsupported membranes (22,23,29–32).
This behavior is attributed to a 1–2 nm water layer that de-
couples the bilayer from the solid support and allows
‘‘lateral’’ lipid-lipid and ‘‘vertical’’ leaflet-leaflet interactions
to dominate (33–35). Substrate effects have been reported,
however, and include slower diffusion rates for probes prox-
imal to the substrate (36) and altered phase behavior (37,38).
The latter may be due to unrelieved stresses at domain
boundaries created during bilayer formation and/or temper-
ature cycling (39). Our results do indicate local heterogene-
ities in gel domain structure and a slow mobility component in
the phospholipid probes. However, it is not clear whether
those can be attributed to substrate effects or defects induced
by the probes.
MATERIALS AND METHODS
Lipids and proteins
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), and GM1 ovine brain ganglioside
(GM1) were purchased from Avanti Polar Lipids (Alabaster, AL) and used
without further purification. N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-
diaza-s-indacene-3-propionyl)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanol-
amine (BODIPY-DPPE, also known as BODIPY-DHPE), 2-(4,4-difluoro-5,
7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-1-hexadecanoyl-sn-
glycero-3-phosphocholine (BODIPY-C12-DHPC), N-(4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)-C5-ganglioside GM1
(BODIPY-C5-GM1), biotinylated recombinant CTX-B subunit (B-CTX-B),
Alexa Fluor 488 conjugated recombinant CTX-B subunit (Alexa-488 CTX-B),
and Alexa Fluor 488 hydrazide were purchased from Molecular Probes
(Eugene, OR) and used without purification unless otherwise indicated.
Sodium meta-periodate and bovine brain asialoganglioside-GM1 were
purchased from Sigma Chemical (St. Louis, MO) and used without further
purification. It should be noted that the use of recombinant Alexa Fluor 488
CTX-B greatly reduces background emission that is found when non-
recombinant CTX-B is used (28).
Synthesis of headgroup-labeled GM1 ganglioside
Alexa Fluor 488 hydrazide-conjugated GM1 (‘‘Alexa-488 head-GM1’’) was
prepared by a modification of previous methods (40). Bovine brain
asialoganglioside-GM1 (1 mg/mL) was suspended in 100 mM sodium
acetate buffer (pH 5.5) with 1 mM sodium meta-periodate. The oxidation
reaction was allowed to proceed for 30 min on ice. The suspension was then
purified and concentrated by ultrafiltration in the same buffer using YM-30
Microcon centrifugal filters (Millipore, Bedford, MA), repeating five times
to remove the sodium-meta periodate. A total of 10 mM Alexa Fluor 488
hydrazide was added to the oxidized GM1 and allowed to react with
agitation for 2 h at room temperature. The fluorescent GM1 conjugates were
freed of unreacted dye by using YM-30 Microcon centrifugal filters,
repeating in PBS buffer, as described above, until the supernatant was
optically clear. The labeled GM1 was dried under vacuum and stored as
a powder under nitrogen at 20C. Based on the mass of the GM1 before
and after dye conjugation and absorption measurements, the Alexa:GM1
ratio was determined to be unity.
Supported bilayers
Lipid bilayers are formed on glass coverslips by the method of vesicle fusion
(29,35). Small unilamellar vesicles are prepared by first dissolving the lipids
in chloroform (Alexa-488 head-GM1 was dissolved in dimethyl sulfoxide),
followed by rotary evaporation of the solvent and drying for over 12 h under
high vacuum. The lipids are resuspended by adding phosphate-buffered
saline (PBS) buffer (100 mM NaCl, 40 mM sodium phosphate, pH 7.4)
and vortexing, followed by degassing with nitrogen. The lipid suspension
was then subjected to a freeze thaw cycle followed by repeated extrusion
(Northern Lipids, Vancouver, Canada) through 100 nm filter pores. Dynamic
light scattering characterization (Protein Solutions, High Wycomb, UK)
verified 100 nm vesicle diameters.
Glass coverslips (0.13–0.17 mm thickness) are cleaned in (7:3) H2SO4/
H2O2 (caution: this is potentially explosive when reacting with organics),
rinsed thoroughly in distilled water and ultrapure water (Barnstead Nanopure,
Dubuque, IA), and stored under ultrapure water (18 MV-cm). Just before use,
the coverslips are dried under a stream of pure, dry nitrogen and mounted in
a Leiden coverslip dish (Harvard Apparatus, Holliston, MA). The ;3 mM
vesicle solution is pipetted onto the coverslip and diluted (1:5) with imaging
PBS buffer (150 mM NaCl, 50 mM sodium phosphate, 1. 5 mM NaN3,
pH 7.4). After 2 h of incubation at 60C followed by 30 min of cooling to
room temperature, the lipid bilayer is rinsed thoroughly with imaging PBS
buffer and mounted on the microscope. When required, incubation of
the lipid bilayers with Alexa 488-CTX-B or B-CTX-B stock solutions
(10 mgr/ml, in imaging PBS buffer) is performed for 1–2 min, followed by
thorough rinsing with imaging PBS buffer.
AFM and ﬂuorescence microscopy
The experimental apparatus for obtaining simultaneous AFM and
fluorescence images of lipid bilayers has been described previously and
will be summarized here (28). An inverted microscope was modified to
accommodate an AFM scan head and is mounted on an acoustically and
light-baffled vibration isolation air table. The liquid cell (coverslip dish) is
mounted on a flat-plate, closed-loop XY scanner (Mad City Labs, Madison,
WI). Excitation light from a continuous 488 nm Ar1 laser on a separate table
is coupled into a single-mode optical fiber that forms a collimated Gaussian
output beam. The beam reflects off a dichroic mirror and underfills (;80%)
the back plane of a 1003 (1.3 NA) oil immersion objective. The latter is
used to optimize two-dimensional imaging and FCS work at the flat interface
of the supported bilayer and the glass coverslip (41). The objective focuses
the light (300 nW) to a diffraction-limited ;400 nm spot (see below)
spatially coincident on the sample with the pyramidal tip on the end of the
AFM cantilever, as can been seen through the microscope eyepiece. This
alignment remains fixed as the sample is scanned. The optical resolution of
the fluorescence image is optimized by minimizing the spot size on the
sample. Epifluorescence emission passes through two notch filters (488 and
670 nm) and a 500–580 nm band-pass filter and is then spatially filtered
by a 50-mm diameter core multimode fiber connected to an avalanche
photodiode detector. Before a scan, the fluorescence signal from the min-
imized laser spot is optimized by the lateral and translational position of
this 50-mm aperture.
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Simultaneous AFM topographic and fluorescence images are acquired by
a single controller for sample scanning, AFM feedback, and photon counting
of the fluorescence. Closed-loop control of the XY scanner is performed
automatically by separate electronics that are interfaced to the imaging
controller. The XY scanner plate was calibrated with a 463 nm square grid
grating (Ted Pella, Redding, CA), and the AFM head was calibrated in Z
with known 25.5 nm steps (TGZ01, NT-MDT, Mikromasch USA, Portland,
OR). Fluorescence background count rates for blank substrates were
,1 KHz. A slight offset between the two images is possible due to the
manual alignment of the laser focus on the AFM probe tip. All the AFM data
presented here were acquired with cantilevers (Olympus TR400-PSA, Tokyo,
Japan, nominal force constant of 0.08 N/M) in tapping mode.
Fluorescence correlation spectroscopy
FCS was performed with the AFM-fluorescence imaging apparatus discussed
above in conjugation with a correlator (ALV-6010/160, Langen, Germany)
interfaced to a separate computer using software supplied with the correlator
(ALV Correlator Software Version V.3.1.12). Calibration of the laser spot
size (1/e2 Gaussian radius ¼ 0.22 mm for 488 nm light) on the surface of the
coverslip at the same power level (300 nW) and same optical pathway used
for all imaging and FCS was determined by fitting the diffusion data acquired
for a 107 M solution of rhodamine 6G in a coverslip dish to the value
2.83 106 cm2/s (42). Precise control of the laser spot position on the sample
was maintained by the closed-loop XY scanner, which eliminates drift and
nonlinearities common to piezoceramic actuators used in AFM (43). The
laser spot focus and the 50-mm multimode fiber spatial filter are optimized as
discussed above for imaging. FCS data acquisition was performed as follows:
1), 2563 256 pixel AFM and fluorescence images of supported bilayers were
acquired and stored in memory; 2), the AFM cantilever was withdrawn from
the sample to minimize light scattering (a precaution, not a problem); 3), the
APD signal output was disconnected from the fluorescence imaging photon
counter and connected directly to the correlator with an impedance-matched
cable; 4), the fluorescence image was displayed and, with an image controller
cursor, the position of the XY scanner was moved to a spot in the fluorescence
image; and 5), FCS data was acquired for 100 seconds at that spot. The
correlator also monitored the fluorescence count rate so that photobleaching
could be detected if occurring. Steps 4 and 5 were repeated for many different
spots in the fluorescence image. The raw FCS data were not averaged at one
spot, but rather many spots were sampled and analyzed independently. Dif-
fusion coefficients were then averaged, unless otherwise noted.
Analysis of FCS data for two-dimensional translational diffusion has
been thoroughly discussed elsewhere (11–13) and will be briefly summarized
here. Fluctuations dF(t) ¼ F(t)  ÆF(t)æ in the fluorescence intensity F are
autocorrelated over discrete time intervals t by the function G(t):
GðtÞ ¼ ÆdFðtÞdFðt1 tÞæ=ÆFæ2: (1)
Brownian diffusion has a mean square displacement Æx2æ ¼ 4D t, where
D is the sought after diffusion coefficient. It can be shown that for fluores-
cence fluctuations due to two-dimensional diffusion of N molecules (11)
GðtÞ ¼ 1
N
+
j
Cj
ð11 t=td;jÞ; (2)
where td,j ¼ w2/4Dj is the average residence interval for molecular
component j with fraction Cj within the confines of the Gaussian beam waist
w. Other factors that may contribute to fluorescence fluctuations, such as
single-triplet intersystem crossing (44), were found to be negligible for the
dyes and timescales used in these experiments. For labeled probe molecules
of one type undergoing unrestricted lateral diffusion, Eq. 2 reduces to a single
component (D) fit. However, if sample heterogeneities exist, the data may
exhibit two components, ‘‘fast’’ and ‘‘slow’’, with fractions Cfast and Cslow
and diffusion coefficients Dfast and Dslow, respectively.
RESULTS AND DISCUSSION
Simultaneous AFM-ﬂuorescence imaging
of probe partitioning
In this section, we present simultaneous AFM-fluorescence
images of bilayers (all 3:1 DOPC/DPPC) having various
headgroup- and tailgroup-labeled GM1 and phospholipid
analog fluorescent probes. The images are acquired under
the same optical conditions that are subsequently used for
the FCS experiments. Thus they not only provide information
with regard to domain structure and probe partitioning but
also serve as ‘‘maps’’ to guide the location of the FCS data
acquisition. The probe concentrations are ;0.05% so that
both imaging and FCS can be performed on the same sample
in sequence. These low probe concentrations preclude precise
quantitative partitioning analysis; thus only qualitative char-
acterization is presented.
Since, as we discuss below, the presence of fluorophores
can change the partitioning of lipids between liquid-dis-
ordered and gel domains, we begin by discussing simulta-
neous AFM-fluorescence images of bilayers that contain
0.5% unmodified GM1 that partitions strongly into the tightly
packed DPPC gel domains (17,45). (We used 0.5% GM1
rather than 0.05% to make certain that a detectable amount is
in the DOPC fluid phase for FCS discussed below.) In Fig. 1
A, it can be seen from the AFM topography that the DPPC
forms (bright) irregularly shaped gel domains. The DPPC-
DOPC height difference is 1.1 6 0.2 nm, in agreement with
other studies (26,46). When the unlabeled GM1 is stained
by bound Alexa-488 CTX-B (17,45), the DPPC domains
become 3.5 6 0.2 nm higher that the DOPC fluid phase, in
agreement with neutron reflectivity measurements (47). The
Alexa-488 CTX-B is closely packed and uniformly covers
the gel domains, indicating significant GM1 concentration.
The GM1 preference for the gel domains is also clearly veri-
fied in the fluorescence image (Fig. 1 B), where the bright
domains correlate with the AFM topography. The resolution
FIGURE 1 Simultaneous 5 mm AFM topography (A) and fluorescence
(B) images (scale bar¼ 1 mm) of a 3:1 DOPC/DPPC with 0.5% GM1 bilayer
on glass. The GM1 partitions to the DPPC domains where it binds Alexa-
488 CTX-B. In the topography image, the bright DPPC domains usually are
1.16 0.2 nm higher than the surrounding DOPC; in this case, having bound
Alexa-488 CTX-B, they are 3.5 6 0.2 nm higher. The fluorescence feature
indicated by the arrow in B is resolved with a full width at half-maximum of
;300 nm.
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of the smallest domains in the fluorescence image is at the
diffraction limit (;300 nm full width half height), consistent
with the FCS Gaussian beam waist calibration discussed in
the previous section.
The partitioning in the 3:1 DOPC/DPPC domain structure
of three probes used in this study differs considerably from
that of unlabeled GM1. From the images shown in Fig. 2, one
can see that the dark regions of the fluorescence images (indi-
cating exclusion of the probe) correlate with the DPPC gel
domains in the topography images (bright areas 1.16 0.2 nm
higher than DOPC). Thus the ‘‘tailgroup-labeled GM1’’
(BODIPY-C5-GM1) in Fig. 2, A and B, the ‘‘tailgroup-labeled
phospholipid’’ (BODIPY-C12-DHPC) in Fig. 2, E and F,
and the ‘‘headgroup-labeled phospholipid’’ (BODIPY-DHPE)
in Fig. 2, G and H, are all excluded in varying degrees from
the DPPC gel domains. The same probes, as well as similar
probes using different fluorophores, have exhibited exclu-
sion from ordered domains in other supported and un-
supported monolayers (16,17,45,48) as well as bilayer
vesicles (20,49). The presence of the fluorophore on saturated
FIGURE 2 Simultaneous AFM topography (middle row) and fluorescence (bottom row) imaging of 3:1 DOPC/DPPC bilayers on glass with four different
lipid probes. All images are 5 mm scans (scale bar ¼ 1 mm). In the AFM images, the bright DPPC domains are 1.1 6 0.2 nm higher than the surrounding
DOPC. In the fluorescence images, the dark regions (less intensity) indicate exclusion of the probe lipids. In A and B, the probe is 0.05% BODIPY-C5-GM1. In
C and D, the probe is 0.03% Alexa-488 head-GM1. In E and F, the probe is 0.05% BODIPY-C12-DHPC. In G and H, the probe is 0.05% BODIPY-DHPE.
Structures of the probes (top row, above corresponding AFM and fluorescence images) are illustrative and meant for relative comparison. For the Alexa-488
head GM1, it is not known which sugar group binds the Alexa-488 hydrazide.
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tailgroups thus sufficiently perturbs the local packing of the
lipid chains to be excluded from the ordered DPPC domains
(19). This is expected for the short chain position of the
BODIPY-C5-GM1. However, even the long-chain position
of BODIPY-C12-DHPC does not improve its accommoda-
tion in the DPPC. Even more surprising, perhaps, is the ex-
clusion of the BODIPY-DHPE, since the unaltered saturated
acyl chains match DPPC. The exclusion from DPPC gel
domains of other headgroup-labeled lipids derived from
DPPE have also been reported for unsupported monolayers
and bilayers (45,50). It should be pointed out, however, that
partitioning is not solely driven by lipid phase. For example,
in DLPC/DPPC mixtures with coexisting phases, N-rhoda-
mine-DHPE was found to favor the DPPC gel phase (51). This
is most likely due to more favorable hydrophobic matching.
The one exception to exclusion from DPPC seen in Fig. 2
is the preference for DPPC domains of Alexa-488 head-GM1
(Fig. 2, C and D). It is thus very significant that the large
GM1 headgroup, even when conjugated with Alexa-488, is
accommodated in the densely packed, ordered DPPC do-
mains. Since all the partitioning results depicted in Fig. 2
have been observed in unsupported bilayers as well, we can
conclude that probe partitioning in these supported bilayers
does not appear to be qualitatively influenced by substrate
interactions but rather by interactions in the bilayer.
The irregular shapes of the DPPC gel domains have also
been observed in unsupported vesicles (20,49,52). The large
domains in Fig. 2 are most likely formed by diffusion-limited
Ostwald ripening at the expense of smaller domains during
cooling of the sample to room temperature (53). However,
apparent pockets of trapped DOPC and fluorescent probes in
some DPPC domains (e.g., Fig. 2 H) suggest that aggregation
also occurs to some extent during the cooling period. All
features in the AFM images are static at room temperature.
There are some very small (,50 nm) gel domains present as
well. These small domains are well below the optical re-
solution in the fluorescence images and thus would never be
seen in a fluorescence-only study. Finally, another observa-
tion reported in vesicle studies (20,49) is the symmetrical
distribution of lipid domains across the bilayer, indicating
strong coupling of the two monolayer leaflets. Evidence for
similar behavior here can be found in the consistent correla-
tion of domains in the topographic images with all features in
the fluorescence images; e.g., there has been no observation
in the fluorescence images of domains in the lower leaflet
(proximal to the substrate) that do not have a corresponding
topographic domain in the upper (distal) leaflet.
Site dependence of local mobility
In this section, we discuss the results of site-specific FCS
measurements that relate to structural features in the
AFM/fluorescence images, specifically DPPC domains and
DOPC/DPPC domain boundaries. Since FCS can be readily
performed at low probe concentrations (11), there is sufficient
sensitivity for data acquisition in the dark regions of the
fluorescence images. For the sake of clarity, we show only the
fits to the FCS data in Figs. 4–7; representative FCS data can
be seen in Figs. 8 and 9. With respect to domain boundaries, it
is of particular interest to see if mobility in the DOPC phase is
influenced by the proximity of ordered DPPC domains due to
extended ordering (30) or to strains associated with boundary
line tensions and/or gel domain formation (39). There are two
important aspects of data acquisition that are imposed by the
diffraction-limited optical resolution. These are illustrated
in Fig. 3, where we have superimposed the DPPC domain
boundaries, as determined from AFM, on the corresponding
fluorescence image. Also depicted is the approximate FCS
spot size (;400 nm) relative to the domain features. The first
aspect to note is that the domain boundaries will always be
blurred in the fluorescence images relative to the AFM to-
pography. One can see in Fig. 3 that the true (AFM) bound-
aries are in the ‘‘gray’’ or intermediate intensity region of the
fluorescence images. Since there can be an offset between the
AFM and fluorescence images, we must use the fluorescence
image to position the FCS spot. Thus we rely on these gray
regions to select domain boundaries. Although the spot selec-
tion may be somewhat imprecise relative to the AFM image,
the stability of the location is maintained by the closed-loop
scanner. The second aspect to point out is that the smaller
domains (,500 nm) tend to have diminished contrast in the
fluorescence image. Since they stand out nicely in the AFM
image, we can refer to the AFM data to verify that they are
indeed domains.
In Fig. 4, we show very large differences in the mobility
of Alexa-488 head-GM1 depending on the location of the
FIGURE 3 Overlap of simultaneous AFM and fluorescence images of
0.05% BODIPY-C12-DHPC taken from Fig. 2, E and F. For clarity, the
AFM topographic image (Fig. 2 E) was processed in Adobe Photoshop (San
Jose, CA) to display just the line edges of the DPPC domains. The white
circle (used also as scale marker) is the approximate size of the calibrated
FCS spot (400 nm diameter). It is located at a domain boundary that appears
‘‘gray’’ (intermediate intensity) in the fluorescence image.
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FCS measurement in the bilayer. The mobility in the DOPC
region (crosses in Fig. 4 B, solid curves in Fig. 4 A) is
consistently rapid (D . 108 cm2/s) and independent of
location. Meanwhile, representative data for FCS locations
inside the DPPC gel domains (triangles in Fig. 4 B, dotted
curves in Fig. 4 A) reflect immobility (D , 1011 cm2/s),
which is verified by significant photobleaching. Similar FCS
results were reported for DOPC/DPPC mixed vesicles (21).
Thus the dense packing of the gel domains accommodates
the Alexa-488 head-GM1, given the bright fluorescence in
these regions, but also completely prevents mobility. For
those points selected along the boundaries, the FCS data is
characterized by distinct two-component fits reflecting the
heterogeneity of the lipid packing at the domain boundary.
Examples are shown in Fig. 4 (diamonds in Fig. 4 B, dashed
curves in Fig. 4 A). The Dfast components of the two-
component curve fits shown here range from 7–9 3 109
cm2/s, the Dslow components range from 0.3–1.4 3 10
10
cm2/s, and Cfast/Cslow ranges from 1–2. The multiple dif-
fusion coefficients suggest a contribution from both fluid
DOPC and gel DPPC phases, although according to the
AFM map these FCS spots were predominately in the DOPC
phase. We do not see evidence of a smooth transition in
mobility between the two phases, and it is possible that the
FIGURE 4 Representative FCS measurements in regions of supported bilayer of 3:1 DOPC/DPPC with 0.03% Alexa-488 head-GM1. (A) Fits to normalized
autocorrelation curves (data curves not shown for clarity) acquired at specific sites indicated in fluorescence image (B). Diffusion coefficients are discussed in
text. The solid curves are for DOPC regions marked by crosses, the dashed curves are for DOPC/DPPC boundary regions marked by diamonds, and the dotted
curves are for DPPC domains marked by triangles. (B) Fluorescence image of Alexa-488 head-GM1, where bright regions are DPPC gel domains. (C) AFM
topography acquired simultaneously with fluorescence image. Bright features are DPPC domains 1.16 0.2 nm higher than the surrounding DOPC. The circles
are the approximate size of the calibrated FCS spot and correspond to the locations selected in the fluorescence image. Images (B and C) are 5 mm scans (scale
bar ¼ 1 mm).
FIGURE 5 Representative FCS measurements in regions of supported bilayer of 3:1 DOPC/DPPC with 0.05% BODIPY-C5-GM1. (A) Fits to normalized
autocorrelation curves (data curves not shown for clarity) acquired at specific sites indicated in fluorescence image (B). Diffusion coefficients are discussed in
text. The solid curves are for DOPC regions marked by crosses, the dashed curves are for DOPC/DPPC boundary regions marked by diamonds, and the dotted
curves are for DPPC domains marked by triangles. The selected dashed curve (arrow) corresponds to data acquired at diamond indicated by arrow in (B). The
selected dotted curve (arrow) corresponds to data acquired at triangle indicated by arrow in (B). (B) Fluorescence image of BODIPY-C5-GM1, where dark
regions represent exclusion from DPPC gel domains. (C) AFM topography acquired simultaneously with fluorescence image. Bright features are DPPC
domains 1.1 6 0.2 nm higher than the surrounding DOPC. The circles are the approximate size of the calibrated FCS spot and correspond to the locations
selected in the fluorescence image. Images (B,C) are 5 mm scans (scale bar ¼ 1 mm).
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nearby DPPC gel domain is influencing the Alexa-488 head-
GM1 mobility in the DOPC phase.
In the case of BODIPY-C5-GM1, many probes along the
domain boundaries appeared to be fully mobile. Represen-
tative data are shown in Fig. 5 where one can see that there is
little difference in the mobility of those lipids along the
domain boundary (diamonds in Fig. 5 B, dashed curves in
Fig. 5 A) with those in the DOPC phase (crosses in Fig. 5 B,
solid curves in Fig. 5 A). One exception (diamond indicated
by arrow in Fig. 5 B) has a distinct two-component fit that
most likely reflects a significant immobile fraction from the
DPPC domain (Dfast  2 3 108 cm2/s, Dslow  3 3 1011
cm2/s, and Cfast/Cslow  2). Inside the larger DPPC domains
(.1mm), the BODIPY-C5-GM1 probes are immobile. How-
ever, we have detected instances (highlighted triangle in
Fig. 5 B, dotted curves in Fig. 5 A) of significant mobility
inside smaller domains. The corresponding autocorrelation
curve is another distinct two-component fit, with Dfast  13
108 cm2/s, Dslow  23 1011 cm2/s, and Cfast/Cslow  1.1.
Thus it appears that we have detected heterogeneities in
DPPC gel domains.
We saw in Figs. 4 and 5 that the GM1 probes, particularly
Alexa-488 head-GM1, exhibit the expected large changes in
mobility when the FCS interrogation spot is moved from
DOPC to DPPC domains. Alexa-488 head-GM1 probes are
immobile in the smallest DPPC domains (,1 mm) that still
fully contained the FCS spot without overlapping the
boundary, whereas the BODIPY-C5-GM1 does exhibit
limited mobility in some submicron DPPC domains. In
stark contrast, however, we unexpectedly find that the
FIGURE 6 Representative FCS measurements in regions of supported bilayer of 3:1 DOPC/DPPC with ;0.05% BODIPY-DHPE. (A) Fits to normalized
autocorrelation curves (data curves not shown for clarity) acquired at specific sites indicated in fluorescence image (B). Diffusion coefficients are discussed in
text. The solid curves are for DOPC regions marked by crosses, the dashed curves are for DOPC/DPPC boundary regions marked by diamonds, and the dotted
curves are for DPPC domains marked by triangles. The selected dashed curve (arrow) corresponds to data acquired at diamond indicated by arrow in B. (B)
Fluorescence image of BODIPY-DHPE, where dark regions represent exclusion from DPPC gel domains. (C) AFM topography acquired simultaneously with
fluorescence image. Bright features are DPPC domains 1.16 0.2 nm higher than the surrounding DOPC. The circles are the approximate size of the calibrated
FCS spot and correspond to the locations selected in the fluorescence image. Images (A and B) are 5 mm scans (scale bar ¼ 1 mm).
FIGURE 7 Representative FCS measurements in regions of supported bilayer of 3:1 DOPC/DPPC with ;0.05% BODIPY-C12-DHPC. (A) Fits to
normalized autocorrelation curves (data curves not shown for clarity) acquired at specific sites indicated in fluorescence image (B). Diffusion coefficients are
discussed in text. The solid curves are for DOPC regions marked by crosses, and the dotted curves are for DPPC domains marked by triangles. (B) Fluorescence
image of BODIPY-C12-DHPC, where dark regions represent exclusion from DPPC gel domains. (C) AFM topography acquired simultaneously with
fluorescence image. Bright features are DPPC domains 1.16 0.2 nm higher than the surrounding DOPC. The circles are the approximate size of the calibrated
FCS spot and correspond to the locations selected in the fluorescence image. Images (A and B) are 5 mm scans (scale bar ¼ 1 mm).
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mobility of the BODIPY-DHPE and BODIPY-C12-DHPC
probes in DPPC domains of similar submicron size is almost
indistinguishable from that in the fluid DOPC. An example
of the surprising results is shown in Fig. 6, where a series of
FCS curves were acquired for BODIPY-DHPE at indicated
locations in and around DPPC domains that are ;0.5 mm in
size. The mobility inside these DPPC domains (triangles in
Fig. 6 B, dotted curves in Fig. 6 A) is almost the same as that
in the DOPC regions (crosses in Fig. 6 B, solid curves in
Fig. 6 A). The only curve that has a significant slow compo-
nent (indicated by arrow) was acquired on a domain bound-
ary (Dfast  3 3 108 cm2/s, Dslow  4 3 1010 cm2/s,
Cfast/Cslow 0.7). Similar behavior is observed for BODIPY-
C12-DHPC in ;700 nm domains (Fig. 7). We found immo-
bility only at the center of large DPPC domains (.1 mm)
where the fluorescence intensity is at a minimum (not shown).
The apparent ‘‘fluidity’’ of these submicron DPPC do-
mains for BODIPY-DHPE and BODIPY-C12-DHPC must
indicate a large degree of heterogeneity. Marked hetero-
geneities have been reported for unsupported bilayers that
contain phase-separated domains (50) as well as for pure
DPPC in both supported and unsupported bilayers (32). In the
case here, formation of the gel domains could be disrupted by
DOPC clusters surrounding the BODIPY-labeled phospho-
lipid probes like surfactants (54). In the darkest regions of
the larger domains (.1 mm), the DPPC appears to be more
homogeneous (at least the phospholipid probes are being
excluded to a larger extent), which explains why the mobil-
ity there is curtailed. Future studies should examine domain
heterogeneity versus probe concentration and domain size.
If the phospholipid probes somehow disrupt the DPPC
packing, the opposite may be true for the unmodified GM1
and Alexa-488 head-GM1. Given the preference of GM1 and
Alexa-488 head-GM1 for the DPPC gel domains, they most
likely do not disrupt the dense, ordered packing of the DPPC.
Thus those DPPC domains containing Alexa-488 head-GM1,
for example, may be more homogenous, rendering the probe
immobile. Possible evidence for this notion is the observation
in Fig. 4 that the boundary FCS curves data showed an
immobile component that indicates uniform, tight DPPC
packing up the domain boundary. Another factor concerning
immobility in the DPPC domains for both Alexa-488 head-
GM1 and BODIPY-C5-GM1 probes is that they may undergo
significant clustering (46,55); however, we see no evidence of
large-scale clustering in the AFM topography or fluores-
cence. In the next section, we show that the only evidence for
clustering occurs due to CTX-B binding, which reduces
mobility in the fluid DOPC phase.
Diffusion in liquid-disordered DOPC regions:
binding of CTX-B to GM1
In this section, we examine effects of CTX-B binding on the
mobility of the GM1 components in the DOPC fluid phase.
First of all, we find that the location of the fluorophore has
little or no effect on the diffusion of the free (unbound)
BODIPY-C5-GM1 and Alexa-488 head-GM1 in DOPC,
whereas we saw above (e.g., Fig. 2) that it has a large effect on
partitioning between fluid and gel domains. When BODIPY-
C5-GM1 is bound to B-CTX-B, the diffusion is slowed by at
least a factor of six relative to the unbound BODIPY-C5-GM1
(see Fig. 8, C and D). Since the asialoganglioside-derived
Alexa-488 head-GM1 cannot bind CTX-B (56), we instead
FIGURE 8 Effects of CTX-B binding on lateral diffusion of GM1 in
DOPC regions of 3:1 DOPC/DPPC bilayers. Typical normalized autocor-
relation curves of (A) 0.03% Alexa-488 head-GM1; (B) trace amounts of
GM1 in DOPC bound to Alexa-488-CTX-B; (C) 0.05% BODIPY-C5-GM1;
and (D) 0.05% BODIPY-C5-GM1 bound to B-CTX-B. The solid curves are
fits to the data (dotted curves). Diffusion coefficients are discussed in text
and summarized in Table 1.
FIGURE 9 One-component versus two-component fits to normalized
autocorrelation curves for lateral diffusion in DOPC. (A) Typical curve fits to
BODIPY-DHPE and BODIPY-C12-DHPC autocorrelation curves (in this
case, BODIPY-DHPE), where the dotted curve is the normalized auto-
correlation data, the solid curve is the best two-component fit, and the dashed
curve is the best one-component fit. It is clear from the curves and the
residuals (below) that a two-component fit is required. (B) Typical curve fits to
unbound Alexa-488 head-GM1 and BODIPY-C5-GM1 autocorrelation
curves (in this case, Alexa-488 head-GM1), where the dotted curve is the
normalized autocorrelation data, the solid curve is the best two-component fit,
and the dashed curve is the best one-component fit. The residuals indicate
a close fit for the one-component model, but the two-component model is
slightly better. Diffusion coefficients are discussed in text and summarized in
Table 1.
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compare its diffusion to trace amounts of native GM1 in
DOPC that are bound to Alexa-488-CTX-B (Fig. 3, A and B).
Once again, we observe that the diffusion of the Alexa-488-
CTX-B-bound GM1 is slower, by a similar factor, than the
unbound Alexa-488 head-GM1. These results are consistent
with the notion that CTX-B forms pentamers that may bind up
to five GM1 molecules in a cluster (47). A large cluster, that
probably includes DOPC matrix lipids as well, is expected to
move at a slower rate. Similar mobility changes with
clustering have been observed for peptides in vesicles (57).
The data contrast sharply, however, with measurements
recently reported (14) for Alexa-488-CTX-B-bound GM1
diffusion in vesicles that are comparable to unbound lipid
probes (5 3 108 cm2/s).
Of particular interest is the mobility data for BODIPY-C5-
GM1 after binding to B-CTX-B. Since the latter is bound
only to the accessible BODIPY-C5-GM1 in the distal leaflet,
one may expect the unbound BODIPY-C5-GM1 in the
proximal leaflet to remain fully mobile, resulting in a distinct
fast/slow two-component fit for the two leaflets. However,
this is not what we observe. We find no evidence for a fully
mobile fast component (Dfast. 10
8 cm2/s). Thus it appears
that a strong coupling between the two leaflets (33) somehow
slows the mobility of the unbound proximal BODIPY-C5-
GM1. One possibility is that interleaflet coupling may induce
clustering of the proximal BODIPY-C5-GM1 in a mirror
image of the B-CTX-B-bound BODIPY-C5-GM1 in the
distal leaflet. An important conclusion, therefore, is that
interleaflet coupling in this model membrane appears to be
more dominant than substrate effects (33).
Diffusion in liquid-disordered DOPC regions:
two-component ﬁts for PC probes
The lateral diffusion coefficients of the GM1 and PC lipid
probes in the liquid-disordered DOPC phase are averages
derived from many (.10) FCS sets taken in each region
determined by AFM topography to be free of DPPC
domains. All the bound and unbound GM1 probes (head-
group-labeled, tailgroup-labeled, and native) have FCS
autocorrelation curves that generally fit fairly well with
a one-component (D) lateral diffusion model. Two-compo-
nent fits (Dfast and Dslow) are always better, of course, but
also have greater variability among the FCS curves (hence
the larger SDs). Thus we have tabulated both sets of fits in
Table 1. Surprisingly, the data also suggest no clear evidence
of a slow component that would arise from a strong inter-
action of the large GM1 headgroup with the substrate.
However, the case is very different for BODIPY-DHPE
and BODIPY-C12-DHPC data in DOPC. These probes
always require a two-component fit in the lateral diffusion
analysis. The difference can be seen in Fig. 9, where we show
a representative FCS curve from BODIPY-DHPE (Fig. 9 A)
that requires a two-component fit and a representative FCS
curve from Alexa-488 head-GM1 (Fig. 9 B) that has a one-
component fit. There are possible systematic artifacts that
may lead to poor one-component fits (58,59), due primarily
to inadequate control over optical parameters. In the case
here, we have appropriately optimized those parameters (see
Materials and Methods) and have exercised great care to
maintain a constant laser intensity, spot size, and spatial
filter throughout this work. Although artifacts certainly
cannot be dismissed, the fact that we are seeing two-com-
ponent ‘‘effects’’ dominating for one set of probes and not
another dispels systematic error as the cause. Thus we at-
tribute the persistent two-component lateral diffusion of the
phospholipid probes to a physical origin such as substrate
interactions (33,36), bilayer heterogeneities (11,32,50), or
multiple orientations of the probe itself relative to the mem-
brane surface (60,61).
The Dfast diffusion components in Table 1 for unbound
lipid probes (2–4 3 108 cm2/s) are comparable to those
previously measured for phospholipid and cyanine probes in
both supported (22,23,33) and unsupported bilayers (11,21).
It is tempting to attribute the Dslow diffusion component
(0.08–0.4 3 108 cm2/s) to probes in the proximal leaflet
that are pinned by the substrate. Separate FRAP diffusion
measurements of lipid probes in the proximal and distal
leaflets on glass-supported bilayers revealed no difference in
mobility ((1.36 0.2)3 108 cm2/s (33), (3.66 0.5)3 108
cm2/s (22)). Immobile fractions of 10–20% in both leaflets
were also reported. In NMR studies of silica-bead-supported
TABLE 1 Two-dimensional translational diffusion coefﬁcients for labeled lipid probes in DOPC and DPPC
DOPC domains
D*
Dfast* Dslow*
DPPC domains
Lipid probe (one-component fit) (two-component fit) Cfast/Cslow D*
BODIPY-C5-GM1 1.4 6 0.4 3.62 6 0.77 0.29 6 0.13 2.7 6 1.1 ,0.001
BODIPY-C5-GM1 bound to B-CTX-B 0.13 6 0.04 0.68 6 0.15 0.035 6 0.008 0.97 6 0.4 ,0.001y
Alexa-488 head-GM1 1.20 6 0.29 3.61 6 0.72 0.40 6 0.09 1.78 6 0.6 ,0.001
GM1, bound to Alexa-488 CTX-B 0.040 6 0.011 0.50 6 0.10 0.016 6 0.007 0.54 6 0.17 ,0.001
BODIPY-DHPE N/A 3.71 6 0.71 0.16 6 0.05 1.6 6 0.4 .1.0z
BODIPY-C12-DHPC N/A 2.50 6 0.78 0.076 6 0.048 1.24 6 0.3 .1.0z
*(3108cm2/s), 6 SD.
yVariable, some evidence observed for higher mobilities in submicron domains.
zSubmicron DPPC domains; immobility observed for domains .1 mm.
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DPPC bilayers (36), the proximal leaflet was more ordered
and had half the mobility (7.5 3 108 cm2/s, at 55C) of the
distal leaflet.
There are several reasons, however, that we cannot solely
attribute the slow diffusion component to the presence of the
substrate. If the slow component is due to a significant
fraction (Cfast/Cslow varies from;1.2 to 3 in Table 1) of lipids
that are influenced by substrate interactions, it is difficult to
understand why the interactions are significantly less pro-
nounced for the GM1 probes that have a much larger head-
group that the PC probes. This observation also discounts
a notion that slow probe mobilities are due to a greater
viscosity of the proximal leaflet induced by substrate inter-
actions and/or an ordered water layer between the bilayer and
the substrate. Furthermore, a strong interleaflet coupling, as
noted in the previous section, would be expected to transfer
significant substrate effects across the bilayer thereby re-
ducing mobility for both leaflets. Finally, long-range electro-
static interactions with negative charges on the glass substrate
are not considered to be a factor because we used a fairly high
ionic strength buffer (150 mM NaCl PBS) that effectively
shields substrate charges (62). When that buffer was replaced
with 15 mM NaCl PBS buffer, and later with distilled water,
no changes in the FCS data were observed. Interestingly, large
decreases in mobility for both tailgroup-labeled BODIPY-
C12-DHPC and headgroup-labeled rhodamine-DHPE have
been observed in stacked lipid multilayers where Na1 was
increased from 0 mM (;7 3 108 cm2/s) to 110 mM Na1
(;1.4 3 108 cm2/s (63)). The reduced mobility was attrib-
uted to clusters of three or more lipids bound together by
the Na1.
Bilayer heterogeneities in the fluid DOPC phase are dif-
ficult to assess. One advantage of this work is that AFM
topographic maps provide sufficient detail with ,10 nm
resolution to rule out significant defects and domains not ob-
servable with other methods. Since obstructions to diffusion
are mapped out and avoided, we do not attempt to fit the FCS
curves with a time-dependent anomalous diffusion coefficient
D } ta  1, where a varies from 0.7 to 1.0 depending on the
obstacle concentration (30,64). Obvious heterogeneities
due to domain boundaries are shown in Figs. 4 and 5. Subtle
heterogeneities, however, due to local packing or tilting
would not be easily detected by AFM and may not be con-
sidered an obstruction in the anomalous diffusion model. In
any case, for BODIPY-DHPE and BODIPY-C12-DHPC, the
two-component curves are not subject to much variability
since they are consistently observed for all spots in all the
bilayers tested.
Fluorescent labels have been blamed for affecting the
mobility of bound proteins, although it was thought to be due
to the increased size of the complex (65). In the case here,
significant effects to mobility (and partitioning) could be
caused by the tendency for the BODIPY moiety to seek
specific depths in the bilayer (60). In their study of un-
supported DOPC model membranes containing BODIPY
headgroup- and tailgroup-labeled PC probes, Kaiser and
London (60) were able to show that a significant population of
the BODIPY groups, despite their nonpolarity, exhibits
a tendency to be located near the polar region of the bilayer.
The remaining BODIPY groups are buried in the hydropho-
bic depths of the bilayer. Clearly, for the tailgroup-labeled
BODIPY-C12-DHPC, the BODIPY has to ‘‘loop back
toward the surface’’ (60), creating a large perturbation in
the local packing of the surrounding lipids. Similarly, for
BODIPY-DHPE, the BODIPY loops back toward the bilayer
to seek polar groups and/or hydrophobic depths. The local
distortion in the bilayer for such occurrences could involve
many matrix DOPC lipids and thus could cause a loss of
mobility due to the increased ‘‘free area’’ required for motion
(64,66). Furthermore, given this scenario of BODIPY-
induced molecular distortion, it would be very easy to
understand why the phospholipid probes tend to be excluded
from the tightly packed DPPC domains or cause significant
perturbations in the DPPC packing. These effects are
expected to be less pronounced for BODIPY-C5-GM1
because of the closer proximity of the BODIPY label on the
short acyl chain to the polar region of the bilayer. Although
the rhodamine-like label on Alexa-488 head-GM1 may not
distort the orientation of the bulky headgroup, this may also
explain why it is not excluded from the DPPC gel domains.
Many important questions remain, however, as to how much
of an effect local distortion in lipid structure has on mobility.
The roughly linear dependence of lateral diffusion strictly on
surface free area (66) is fairly mild relative to the difference
betweenDfast andDslow diffusion components measured here.
SUMMARY AND CONCLUSIONS
We have demonstrated that two-dimensional diffusion in
supported model membranes can be characterized locally by
instrumentation that provides simultaneous AFM and
fluorescence imaging of lipid domains. The AFM images
not only provide nm-scale lateral resolution and topographic
information but are used to reveal domain partitioning on
the submicron scale of four different fluorescence probes that
are used to obtain mobilities. The four probes were chosen
because they are fluorescent analogs of naturally occurring
lipids and they represent two common labeling schemes
requiring headgroup and tailgroup modification. Overall, we
find that the supported model membranes examined here have
common attributes in structure and fluidity with unsupported
vesicles; however, we have also presented unexpected results
that suggest possible fluorophore effects on probe partition-
ing, domain heterogeneity, and probe mobility.
Partitioning of lipid components into membrane domains
is central to the lipid raft model. We see here that the
exclusion of labeled probes by their unlabeled counterparts
in gel domains is indicative of significant perturbations in
packing and/or lipid interactions, consistent with previous
studies on supported and unsupported model membranes.
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For both saturated phospholipid analogs BODIPY-C12-
DHPC and BODIPY-DHPE, we see that modifications in
either the acyl chain or the headgroup lead to exclusion from
the saturated gel domains. For the GM1 analogs, we find
that BODIPY-C5-GM1 is excluded from the gel domains,
whereas Alexa-488 head-GM1 is not excluded. Thus the
presence of the fluorescent label on the asialoganglioside
headgroup does not interfere with the interactions that allow
GM1 to occupy sites in the gel-phase DPPC.
Equally important in the lipid raft model of membrane
function is the mobility of the lipid components inside and
outside domains. Overall, we found that the mobilities of all
four probes were roughly the same in the DOPC fluid phase.
Thus we found no glaring difference in fluid phase mobility
due to the location of the head- or tailgroup labeling. Both
BODIPY-C5-GM1 and unmodified GM1 were shown to
slow down by at least a factor of six upon binding to CTX-B
fragments, which most likely indicates clustering induced
by the pentameric CTX-B. Mobility of the unbound GM1
analogs is severely attenuated in the gel-phase DPPC. This is
definitely the case for the Alexa-488 head-GM1, indicating
a tight packing by the surrounding DPPC lipids. Further-
more, mobility appears to be restricted around the domain
boundaries. The mobility in DPPC is also restricted for
BODIPY-C5-GM1; however, evidence was presented for
increased mobility in submicron domains that may be due to
DPPC packing heterogeneities. Mobility around the domain
boundaries is higher, resembling, for the most part, that in
the fluid phase. This trend of increasing mobility in and
around the submicron DPPC domains is remarkably
prevalent in the BODIPY-C12-DHPC and BODIPY-DHPE
phospholipid analogs. For these probes there appears to be
little reduction in the lateral diffusion in the submicron
DPPC domains relative to the DOPC regions. It is important
to point out that these unexpected observations for the
phospholipid analogs are not general for all DPPC domain
sizes (immobility was detected in the center of large
domains) and that a comprehensive study on mobilities
versus domain size was not performed. However, the results
presented here for submicron domains may be relevant to
mobility in sphingolipid-cholesterol domains in biological
membranes, where domain sizes are believed to be,100 nm
(3,67). Thus its appears that those lipids such as Alexa-488
head-GM1 and unmodified GM1 that partition into the
DPPC domains do not disrupt the dense packing and thus are
rendered immobile, whereas those lipids that are excluded
on the basis of disrupting the gel packing and/or lipid-lipid
interactions may have greater mobility.
In general, we have shown that FCS can reveal hetero-
geneities in supported lipid bilayers. The phospholipid
probes BODIPY-C12-DHPC and BODIPY-DHPE not only
exhibited a perplexing mobility in submicron DPPC domains
but also required two-component fits to the FCS curves in
the fluid DOPC phase. The slow component could be due
to a variety of factors including substrate interactions and
membrane heterogeneities. However, it could also be due to
local distortion of the molecule and surrounding matrix
lipids by the tendency of BODIPY to seek polar regions
of the membrane. This effect, documented elsewhere (60),
may also be responsible for exclusion of the probes from
close-packed gel domains. In any case, it is clear that the
phospholipid probes, as well as other labeled phospholipids
using different fluorophores, are not ideal for the modeling of
partitioning and mobility in membranes. They do, however,
illustrate that lipid components and lipid-protein complexes
in biological membranes could move rapidly in and out of
raft domains as needed.
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ABSTRACT Simultaneous atomic force microscopy (AFM) and confocal ﬂuorescence imaging were used to observe in
aqueous buffer the three-dimensional landscape of the inner surface of membrane sheets stripped from ﬁxed tumor mast cells.
The AFM images reveal prominent, irregularly shaped raised domains that label with ﬂuorescent markers for both resting and
activated immunoglobin E receptors (FceRI), as well as with cholera toxin-aggregated GM1 and clathrin. The latter suggests that
coated pits bud from these regions. These features are interspersed with ﬂatter regions of membrane and are frequently
surrounded and interconnected by cytoskeletal assemblies. The raised domains shrink in height by ;50% when cholesterol is
extracted with methyl-b-cyclodextrin. Based on composition, the raised domains seen by AFM correspond to the cholesterol-
enriched dark patches observed in transmission electron microscopy (TEM). These patches were previously identiﬁed as sites
of signaling and endocytosis based on their localization of activated FceRI, at least 10 associated signaling molecules, and the
presence of clathrin-coated pits. Overall the data suggest that signaling and endocytosis occur in mast cells from raised
membrane regions that depend on cholesterol for their integrity and may be organized in speciﬁc relationship with the cortical
cytoskeleton.
INTRODUCTION
Models of cell membrane organization are still evolving.
Experimental evidence gathered over several decades sug-
gests that the fluid mosaic model (1) fails to fully account for
the possibility of ordered domains and other evidence of
membrane heterogeneity (2–6). The modern concept that
membranes are made up of distinct and dynamic mixtures of
ordered and disordered lipid domains is based in part on
model membrane studies that dramatically demonstrate phase
separation of lipids, due largely to their state of saturation
(7,8). Evidence for the partitioning of cholesterol and specific
cellular lipids and proteins into ‘‘lipid rafts’’ in cells comes
principally from their detergent insolubility and subsequent
recovery in light fractions of sucrose density gradients (9,10).
Recent evidence from electron microscopy that typical
‘‘raft markers’’, such as glycosylphosphatidylinositol (GPI)-
anchored proteins and GM1 ganglioside, fail to colocalize
either with each other or with signaling receptors confirms
the nonrandom topographical organization of native cell mem-
branes and suggests that microdomains may be much more
numerous and heterogeneous than suggested from biochem-
ical studies (2,11). Membrane domains may also be much
smaller than originally suggested. Several groups have pro-
posed that domains in resting cells are,70 nm in size (12,13).
Using laser trapping and single particle tracking (SPT) tech-
niques, Pralle et al. (14) estimated GPI-linked proteins to reside
in rafts as small as 26 6 13 nm in diameter. In transmission
electron microscopy (TEM) studies of membrane sheets,
Prior et al. (15) found Ras in microdomains of mean radius
226 4 nm. Remarkably, these domains occupied 35% of the
plasma membrane.
Immunogold labeling and electron microscopic imaging
of endogenous proteins in the cytoplasmic face of mast cell
membranes, including the abundant immunoglobin E (IgE)
receptor (FceRI) and its signaling partners, has revealed that
most (if not all) proteins in native membranes are distributed
as small, dispersed clusters before stimulus (2,16,17).
Despite this order, the membrane is adaptable and capable
of dynamic reorganization. This is well illustrated by TEM
observations showing that FceRI can coalesce within minutes
of activation into patches as large as 200–400 nm in diameter
(2,16,17). Because these sites of receptor aggregation accu-
mulate many signaling proteins, they are presumed to be
sites of active signaling. The signaling patches typically oc-
cupy ‘‘dark’’ membrane regions that show enhanced labeling
with osmium, indicating high levels of double bond-
containing lipids and/or cholesterol (2), and are frequently
bordered by coated pits (see Fig. 1 B). It is of great interest,
therefore, to determine if the signaling patches are indeed
distinct topographic features in mast cell membranes.
Here, we complement electron microscopy with atomic
force microscopy (AFM) to further examine the topography
of the cytoplasmic face of plasma membrane sheets stripped
from tumor mast cells (rat basophilic leukemia RBL-2H3).
AFM has been used extensively to characterize biological
samples because it can be routinely performed in natural
fluid environments, which is a clear advantage over vacuum
conditions imposed by the TEM. It has also been well estab-
lished that AFM can provide undistorted images of soft, com-
pliant membrane structures, due in large part to sensitiveSubmittedAugust 31, 2005, and accepted for publicationDecember 14, 2005.
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force feedback detection and use of the tapping mode to
reduce lateral forces (18–21). In model membrane studies,
AFM has been able to map phase-separated lipid domains
(22–24). A key feature of this study is the ability to cor-
relate membrane topographic features with the locations of
fluorescently tagged proteins and lipids through simulta-
neous acquisition of AFM and confocal fluorescence images
(23,24).
Our AFM results show that the inner side of the plasma
membrane is composed of numerous irregular-shaped raised
domains that contain both resting and activated FceRI,
aggregated GM1, and clathrin. When present, a fibrous mesh-
work appears to link adjacent raised domains, suggesting a
role for the cortical cytoskeleton in organizing these promi-
nent features of the plasma membrane landscape. Taken
together, the results identify the raised domains seen in AFM
as the darkened membrane regions seen by TEM. Although
the raised domains are likely to be heterogeneous in content,
they importantly include sites of signaling and endocytosis.
MATERIALS AND METHODS
Antibodies and reagents
The dinitrophenol (DNP)-specific IgE was affinity purified from the ascitic
fluid of mice bearing the H1 DNP-e-26.82 hybridoma (25) and conjugated
to Alexa 488 using a kit supplied by Molecular Probes (Eugene, OR).
Monoclonal antibodies to anti-clathrin heavy chain were purchased from
Calbiochem (San Diego, CA). Alexa-488-conjugated anti-mouse IgG
F(ab9)2 and Alexa-488-conjugated recombinant cholera toxin B fragment
(Alexa-488-CTX-B) were purchased from Molecular Probes. Monomeric
perfringolysin O (PFO) was produced as His-tagged recombinant protein in
Escherichia coli and purified by Ni-NTA affinity chromatography.
Cell culture and treatment
Stock cultures of RBL-2H3 mast cells were maintained in minimal essential
medium (Gibco, Invitrogen, Carlsbad, CA) supplemented with 10%Hybrimax
(Sigma, St. Louis, MO) and passaged twice weekly. Cells were dispensed into
suspension dishes containing 15 mm diameter clean glass coverslips. In some
cases, the cellswere preincubated for 1 hwithAlexa 488 IgE (2mg/ml) to prime
and label the FceRI. Cells were then incubated for 7 min at 37C, plus or
minus polyvalent antigen (DNP-bovine serum albumin (BSA), 0.1 mg/ml),
followed by fixation and sheet preparation (described below). For the GM1
study, cells were treatedwith Alexa 488 cholera toxin for 10min at either room
temperature (RT) or 37C before fixation. For cholesterol depletion, cells were
pretreated for 30 min with 10 mMmethyl-b-cyclodextrin (MbCD) (Sigma) in
MEM containing 10% fatty-acid-free BSA before fixation and sheet prepara-
tion.
Preparation of plasma membrane sheets
for AFM/ﬂuorescence
As shown schematically in Fig. 1, the cytoplasmic face of membrane sheets
were prepared for simultaneous AFM/fluorescence imaging by modification
of the procedure used for TEM imaging (16), described below, and
originated by Sanan and Anderson (26). Ethanol-cleaned 25 mm diameter
glass coverslips were glow discharged, coated with 0.2 mg/ml of poly-L-lysine
for 30 min, rinsed in doubly distilled water for 10 s, and air dried. Cells were
fixed in 0.5% paraformaldehyde in phosphate-buffered saline (PBS) in the
presence of Hoechst 33942 nuclear stain for 7 min at RT, rinsed, and held in
PBS. Next, the monolayer was dipped in HEPES buffer and inverted onto
the center of a poly-L-lysine-coated coverslip, without applying pressure.
The resulting ‘‘sandwich’’ was left for 10 min at RT on moist 4.25 cm filter
paper then separated by floating apart in HEPES buffer. For the clathrin
labeling experiment, coverslips carrying membrane sheets were incubated in
mouse monoclonal anti-clathrin heavy chain for 30 min. This was followed
by rinsing three times in PBS and incubation in the secondary antibody
Alexa 488 F(ab9)2 goat anti-mouse IgG with a 0.1% solution of BSA for 30
min at room temperature. Coverslips were rinsed three times in PBS,
mounted in a coverslip dish (Harvard Apparatus, Holliston, MA), and im-
mediately immersed in PBS for imaging.
Plasma membrane sheet preparation and gold
labeling for TEM
Plasma membrane sheets were prepared and processed for TEM as described
inWilson et al. (16) and shown schematically in Fig. 1. Briefly, coverslips of
live or lightly fixed (0.5% paraformaldehyde for 10 min at 37C) cells were
immersed in ice-cold HEPES buffer (25 mMHEPES, pH 7, 25 mMKCl, 2.5
mM Mg(C2H3O3)2) and inverted onto nickel electron microscopy (EM)
grids that had been coated with formvar and carbon and, on the day of the
experiment, glow discharged and floated on poly-L-lysine (0.8 mg/ml for 30
min, followed by 10 s doubly distilled water rinse and air drying). Pressure
was applied to the coverslip for 20 s by bearing down with a cork. The
coverslips were lifted, leaving sections of the upper cell surface adherent to
the poly-L-lysine-coated grid. Membranes were immediately fixed in 2%
paraformaldehyde for 10 min at 4C. FceRI b-subunits were labeled
from the inside sequentially with primary antibodies and gold-conjugated
secondary reagents by inverting grids onto droplets. Cholesterol on the
inner face of the plasma membrane was labeled using 5 nm colloidal gold
(BBInternational, Cardiff, UK) conjugated to recombinant, monomeric
PFO, using the manufacturer’s instructions. Samples were postfixed in 2%
glutaraldehyde in PBS, stained for 10 min with 1% OsO4 prepared in 0.1 M
cacodylate buffer, and washed 5 min with cacodylate buffer followed by
doubly distilled water. Samples were finally processed for 10 min each in
1% aqueous tannic acid and 1% aqueous uranyl acetate, with intermediate
and final washes in doubly distilled water. Grids were air dried and
examined using a Hitachi 600 transmission electron microscope.
FIGURE 1 Schematic view of the membrane sheet preparation for AFM
analysis. Whole cells are dispensed onto substrates (step 1). A poly-L-lysine-
coated coverslip is lowered (step 2) onto the dorsal surface of lightly fixed
cells to make a ‘‘sandwich’’ that can be separated (step 3), producing a
monolayer of membrane sheets, all oriented with the cytoplasmic face-up
for simultaneous AFM/fluorescence imaging (lower left). A very similar pro-
cedure generates cytoplasmic face-up membrane sheets on nickel grids for
TEM imaging (lower right).
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Simultaneous AFM and ﬂuorescence imaging
The apparatus to obtain simultaneous AFM and confocal fluorescence
imaging has been described in detail elsewhere (23,24). Briefly, an inverted
microscope (Olympus IX70, Tokyo, Japan) was modified to accommodate a
Bioscope AFM head (Veeco, Santa Barbara, CA). The coverslip dish
containing membrane sheets was mounted onto an X-Y piezo scanner plate
(Nanonics, Tel Aviv, Israel). The scanner plate in turn was mounted on a
manual X-Y stage that allowed large range viewing of the sample with a Hg
lamp. In this way, whole cells indicated by the Hoechst nuclear stain were
detected and avoided. The AFM probe was centered on the membrane
sheets, and the Hg lamp was extinguished. Excitation light from a 488 nm
Ar1 laser was focused by a 1003, numerical aperture 1.2 oil objective
(Olympus) to a 300 nm spot and aligned with the AFM probe by visual
inspection. (A slight nanometer-scale offset between fluorescence and AFM
images can occur due to the alignment.) Epifluorescence was spatially
filtered in a confocal manner by coupling into a 50 mm diameter core
multimode fiber connected to an avalanche photodiode detector. AFM and
fluorescence images were acquired with a single controller (RHK, with
SPM32 software). All the AFM data presented here were acquired under
forces,1 nN, with levers (Olympus TR400-PSA, nominal force constant of
0.08 N/M) in tapping mode. The XY scanner plate was calibrated with a 463
nm square grid grating (Ted Pella, Redding, CA), and the AFM head was
calibrated in Z with known 25.5 nm steps (TGZ01, NT-MDT Mikromasch,
Allen, TX). Three-dimensional (3-D) rendering was accomplished using
WSXM freeware (Nanotec, Madrid, Spain).
Analysis of AFM topography
Specific features in the AFM topography were analyzed by line profiling
routines provided in WSXM and SPM32 imaging software (see Fig. 7 for
examples). Each line profile gave both height and width information. The
heights of raised domains are measured relative to the surrounding mem-
brane (not relative to the substrate). Since raised domains were irregularly
shaped, care was taken for each domain to acquire representative profiles.
All the representative height and width data were entered into KaleidaGraph
software (Synergy Software, Reading, PA) for statistical analysis (Table 1)
and histogram binning (see Fig. 9).
RESULTS AND DISCUSSION
Aggregated receptors are found in raised domains
As shown previously (2,16,17), TEM imaging of immuno-
gold-labeled IgE receptors, FceRI, in RBL membrane sheets
reveals recruitment to electron-dense dark patches upon ac-
tivation. The dark patches preexist in resting cells but become
more prominent with FceRI clustering. In Fig. 2 A, IgE-
primed receptors are distributed across the resting membrane
in small clusters. Clathrin lattices (arrow) and clathrin-coated
pits are features of the resting membrane. Upon activation by
the addition of multivalent antigen (Fig. 2 B), FceRI form
large clusters that localize to the characteristic dark patches.
Clathrin lattices and clathrin-coated pits are seen inside and
in close proximity to the dark patches. Budding pits often
contain the IgE receptors after activation, indicating that dark
contrast regions are involved in both signaling and endo-
cytosis (2). Prior work also showed that GM1 is recruited
independently to the same dark patches containing activated
FceRI, after its CTX-B aggregation (2). Thus activated FceRI,
aggregated GM1, and clathrin colocalize in the dark patches.
We began our simultaneous AFM/confocal fluorescence
imaging of resting and activated RBL-2H3 mast cell sheets
with the objective of observing any topographically distinct
membrane features that contained fluorescence-tagged FceRI
IgE receptor. Our technique of membrane harvesting, shown
schematically in Fig. 1, exposes only the cytoplasmic surface
to AFM imaging. However, either surface can be labeled
with a fluorescent tag. Thus in the first experiments, the cells
were primed with Alexa-488-conjugated anti-DNP IgE to
occupy the high affinity IgE receptors that are present on the
extracellular surface at levels approaching 200,000/cell. This
priming step provides a fluorescence tag for receptor tracking
but does not induce signaling responses.
The results for resting and activated cells are shown in Fig.
3, A–F. AFM topographic images of the cytoplasmic surface
of resting membrane sheets reveal raised domains (Fig. 3 A,
arrows). The edge of the membrane sheet can also be seen.
In the resting sheets, the simultaneous fluorescence image
(Fig. 3 B) exhibits semiuniform fluorescence; however, oc-
casional large clusters can be resolved (white arrows, Fig.
3 B). These data are consistent with dispersed clusters of
resting FceRI, containing only a few receptors, that are below
the resolution of the confocal microscope (;300 nm). We do
see, however, that bright regions (white arrows) within the
uniform fluorescence map to the raised domains in the AFM
topography (Fig. 3 A). To accentuate the correlation, we have
used edge-finding routines in Adobe Photoshop (Adobe
Systems, San Jose, CA) to overlay the domain boundaries on
the fluorescence image (Fig. 3 C). After activation induced by
cross-linking IgE-bound receptors with the polyvalent ligand
DNP-BSA, we clearly see raised domains in the AFM to-
pography of the membrane sheets (Fig. 3 D). Moreover, the
semiuniform fluorescence observed in the resting sheets gives
way to strongly clustered, bright foci of FceRI in the acti-
vated sheets (Fig. 3 E). The strong clustering correlates pre-
cisely with the raised domains in the topography (Fig. 3 F).
Cross-linked gangliosides redistribute to
raised domains
Since prior TEM work showed that GM1 aggregated by
CTX-B fragments is recruited independently to the same
TABLE 1 Topographic information
Structure
(No. of measurements)
Domain
height (nm)
Domain
width (nm)
6Standard deviation 6Standard deviation
Flat region of membrane* (5) 7.0 6 0.2 –
Flat region of membrane* (5) 6.8 6 0.7 –
Treated with MbCD
Raised domain, activated (68) 50 6 16 575 6 315
Raised domain, resting (38) 43 6 13 394 6 191
Raised domain, activated (34) 36 6 17 650 6 354
Treated with MbCD
Raised domain, resting (46) 24 6 9 358 6 244
Treated with MbCD
*Relative to poly-L-lysine covered substrate.
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dark patches containing cross-linked FceRI (2), we checked
to see if cross-linked GM1 is present in the raised domains.
In this case, we incubated live, resting RBL-2H3 cells with
Alexa-488-conjugated CTX-B before sheet preparation. As
shown in Fig. 4, A and B, raised domains in the AFM
topographic image (Fig. 4 A) in the resting membrane sheets
do indeed correlate with bright clusters of GM1 stained with
labeled CTX-B (Fig. 4 B). This correlation is made clear in
FIGURE 3 Simultaneous AFM and confocal fluorescence images of FceRI IgE receptor distributions in membrane sheets. The membranes were prepared
from Alexa-488-labeled IgE-primed cells, without (A–C) or with (D–F) 5 min of antigen (DNP-BSA) activation. In the resting membrane (A–C), the white
arrows point to examples of correlation between bright fluorescent IgE spots (B) marking small clusters of resting receptors near the edge of the membrane
sheet that correlate with raised domains in the AFM image (A). In C, we have overlaid the topographic domain edges from A onto the fluorescence image (B) to
confirm that the tagged IgE receptors cluster in ‘‘raised’’ membrane regions. The clustering is much more pronounced for activated receptors (imagesD and E),
where the bright regions in the IgE fluorescence (E) map clearly with the raised domains in the AFM image (D). In F, we have overlaid the topographic domain
edges fromD onto the fluorescence image (E) to confirm the coincidence of receptors and raised domains. The pseudocolor scales indicate the relative height of
membrane features in the AFM images (A and D).
FIGURE 2 TEM images of FceRI IgE
receptor distributions in membrane
sheets, as revealed by 10 nm anti-FceRI
b-gold labels. The membranes were
prepared from IgE-primed cells, without
(A) or with (B) 5 min of antigen (DNP-
BSA) activation. Immunogold labeling
is performed after membrane harvesting.
In resting membranes (A), the receptor is
distributed uniformly in small clusters. In
activated cells (B), it forms large clusters
localized in dark regions. Clathrin-coated
pits are visible and tend to occur on the
edges of the dark regions.
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the overlay (Fig. 4 C). In contrast, there was no correlation
between fluorescence and AFM topographic features when
Alexa-488-cholera toxin was applied to prefixed cells (not
shown). The latter is consistent with the essentially random
distribution of GM1 observed in TEM for prefixed cells (2)
and supports the concept that there are distinct membrane
features on the cytoplasmic face associated with the RBL
signaling patches.
Clathrin-coated vesicles bud from raised domains
Previous TEM studies (2,16) have shown that clathrin-coated
vesicles tend to bud from the dark patches in membrane
associated with FceRI signaling (see pits marked with
arrows in Fig. 2 B). To access the relationship of clathrin to
the raised domains on the cytoplasmic surface that are ob-
served with AFM, membrane sheets were treated with mono-
clonal antibodies to clathrin heavy chain, followed by labeling
with fluorescent anti-mouse antibodies. The results are shown
in Fig. 5. Once again, there is a very good correlation between
raised domains (Fig. 5 A) and the distribution of clathrin
(Fig. 5 B). Thus it is clear that the raised domains contain
clathrin-coated pits. Occasionally, it is possible to resolve
domed structures within large, irregularly shaped raised do-
mains. This can be seen in Fig. 6, A and B, where Fig. 6 B is
an expanded 3-D view of such a feature present in Fig. 6 A.
One possible interpretation of the peaks in the 3-D view is
that clathrin-coated vesicles are budding from a larger raised
domain.
To summarize our results so far, we have seen raised
domains in all the AFM topographic images of the mem-
brane sheets (both resting and activated). All the raised do-
mains appear to label with IgE receptor, GM1 that has been
aggregated by CTX-B, and clathrin. Since all three are known
from the TEM results (2,16,17) to colocalize in the dark
patches, particularly for the activated cells, it is straightfor-
ward to conclude that the dark patches correspond to the
raised domains in AFM topography and represent distinct
topographic feature of these membranes.
Repeated measurements discussed in detail below, and
summarized in Table 1 and Fig. 9, reveal that the height of
the raised domains, relative to the surrounding membrane,
FIGURE 4 Simultaneous AFM (A) and confocal fluorescence (B) images of resting RBL cell membrane sheets where the GM1 ganglioside is aggregated by
Alexa-488-labeled CTX-B before fixation. In B, the upper right corner is dark due to photobleaching. Arrows in the paired images point to examples of
correlation between fluorescent label in B and raised domains in A. In C, we have overlaid the topographic domain edges from A onto the fluorescence image
(B) to confirm the colocalization. The pseudocolor scale indicates the relative height of membrane features in the AFM image (A).
FIGURE 5 Simultaneous AFM (A) and confocal fluorescence (B) images of resting RBL cell membrane sheets where clathrin is labeled with mouse
monoclonal anti-clathrin heavy chain and Alexa 488 F(ab9)2 goat anti-mouse IgG. The raised domains in A correlate strongly with the bright regions in B, thus
clearly indicating the presence of clathrin. In C, we have overlaid the topographic domain edges from A onto the fluorescence image (B) to confirm the
colocalization. The pseudocolor scale indicates the relative height of membrane features in the AFM image (A). In this particular sheet, the raised domains are
reduced in height by treatment with 10 mM MbCD (see Fig. 7).
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ranges from 15 nm to as much as 90 nm. By comparison, the
flatter regions of these native membranes between the do-
mains have an average thickness of;7 nm, measured relative
to the poly-L-lysine-coated substrate. (The edge of a mem-
brane can be seen in Fig. 3 A.) This is not much greater than
the 4.5 nm thickness of a typical model lipid bilayer (27) and
is comparable to the 6.3 nm thickness measured for protein-
containing ‘‘purple membranes’’ of Halobacterium salina-
rum (21). Thus the raised domains are significant protrusions
that are much larger than the overall membrane thickness.
Cholesterol depletion reduces the height of
raised domains
Cholesterol is a key component of the plasma membrane
(28) and its loss has profound effects, including changes in
recovery of specific components in light fractions of sucrose
density gradient used as a biochemical measure of membrane
raft integrity. Cholesterol depletion prohibits the formation
of coated pits (29), leaving the membrane studded with flat
clathrin arrays (arrow, Fig. 7 D) that cannot deliver cargo
to the cell interior. Membrane perturbations associated with
cholesterol depletion have frequently been used as an indi-
cator of raft involvement (30,31). To determine the effects
of cholesterol depletion on the topography of the cytoplas-
mic face, we incubated RBL cells with 10 mMMbCD for 30
min at 37C before fixing cells and preparing membrane
sheets for AFM measurements. Representative results in Fig.
7 demonstrate that the height of the raised domains on RBL
membrane sheets is markedly reduced by cholesterol deple-
tion. When analyzed in line profile or cross section (red lines
in Fig. 7, A and B), a representative raised domain in control
membranes has a peak height of almost 70 nm. By com-
parison, cross sectional analysis of a representative raised
domain in a cholesterol-depleted membrane has a peak height
of only 20 nm (black lines in Fig. 7, A and C). Analyses of
repeated measurements are summarized in Table 1 and Fig.
9. Importantly, the loss of cholesterol fails to significantly
alter the 7 nm thickness of the flat regions of membrane.
Cholesterol is observed in TEM dark patches
In prior work, x-ray spectral analysis of dried membrane
sheets indicated that the dark patches have higher levels of
carbon than bulk membrane (2). This result suggested that
they contain a higher density of proteins and associated
lipids and/or cholesterol than the surrounding membrane.
FIGURE 6 (A) AFM image at higher resolution of a resting RBL cell
membrane sheet (clathrin labeled) showing several raised domains. (B) One
domain (0.4 mm box) was selected for 3-D representation to highlight
possible clathrin pits within the domain.
FIGURE 7 (A) Example of AFM topographic
line profiles of raised domains for both control
RBL cell membrane sheets (B) and those treated
with 10 mM MbCD (C). The measurements show
that the height of individual domains is substan-
tially lower in cholesterol-depleted membranes
(black line) than in control membranes (red line).
The data for all the sheets studied are summarized
in Table 1 and in histograms of Fig. 9. The data
are independent of labeling. Image B was from a
resting cell and image C was from an activated
cell. A representative TEM image of cholesterol-
depleted membranes is shown in D, where ‘‘flat-
tened’’ clathrin arrays can be observed.
Topography of Cellular Membrane Domains 2409
Biophysical Journal 90(7) 2404–2413
Fig. 8 shows two TEM images that support the concept that
cholesterol is an important component of the dark patches
and is thus in good agreement with their coidentity with the
cholesterol-sensitive raised regions seen by AFM. In Fig. 8,
A and B, membrane sheets from control and MbCD-treated
cells were labeled with 5 nm gold particles coated with a mono-
meric form of PFO (32). A toxin produced by Clostridium
perfringens, PFO specifically binds cholesterol and has been
successfully used as a cytochemical probe for electron mi-
croscopy (33). In the control cells (Fig. 8 A), cholesterol is
present in bulk membrane but is markedly clustered in a
large darkened region (arrow, lower left). There is very little
label in the MbCD-treated (cholesterol-depleted) cells (Fig.
8 B). Thus the dark patches contain high levels of cholesterol
as well as proteins.
Quantifying the dimensions of the raised regions
The data above show that raised domains are a consistent
feature of all the membrane sheet preparations studied by
AFM to date. In Fig. 9, eight normalized histograms provide
an expanded analysis of the raised domain heights and widths.
The height and width data are broken down into activated
and resting and with and without the MbCD treatment that
extracts cholesterol. The histogram data are also condensed
in Table 1, which includes the number of measurements for
each structure.We see an increase in both the heights andwidths
of the raised domains for activated cells relative to resting
cells. This is consistent with TEM observations (2,16,17) of
protein recruitment to the dark patches. We see the same
trend after MbCD treatment, which reduces the height of all
raised domains but does not appear to reduce domain widths.
It is important to note that concerning domain widths, the
skewed histograms and large ranges are most likely due to
aggregates of smaller domains. This would also reduce
correlation, if any, between height and widths.
We note that these measurements were made using sheets
labeled with IgE alone and also with sheets exposed to DNP-
BSA and CTX-B on the extracellular side and with Abs to
clathrin on the cytoplasmic side. To address the concern that
these various labels would add substantial thickness to the
membranes, we compared domain heights betweenmembranes
from resting cells that were unprimed with IgE relative to
those that were and between membranes from activated cells
that were labeled with primary and secondary antibodies for
clathrin relative to those that were not.We found no statistical
difference in the height of resting cells that were unprimed
with IgE relative to those that were.We found that the clathrin
labels added nomore than 136 5 nm to the domain height. In
short, we attribute the domain heights to protein clustering
and associated cholesterol and very little, if any, to the labels.
Linking raised domains to the cytoskeleton
The relationship between membrane signaling domains and
the cytoskeleton is of great interest (34). Diffusion confine-
ment zones have been attributed to the cytoskeleton (35,36).
In the mast cell membrane, the cortical cytoskeleton forms a
continuous submembranous meshwork (37). This meshwork
is frequently observed on the inner surface of native mem-
brane sheets in TEM images, where it seems to connect the
darkened membrane areas (Fig. 10 C; also Fig. 8 A). Previous
studies showed that the fibers bind phalloidin-gold particles
and thus contain F-actin (16). When imaged by the AFM
(Fig. 10, A and B), similar networks of fibers (white arrows)
can be seen to surround and connect the raised domains.
This supports the concept that the topography of the inner
membrane is organized in part by the cortical cytoskeleton.
We note that the cytoskeletal fibers are not seen in every
AFM or TEM image of membrane sheets, whereas conven-
tional thin section TEM shows a continuous actin meshwork
under the mast cell membrane (37). Thus it is likely that a
variable degree of cytoskeletal disassembly occurs during
the membrane sheet preparation.
SUMMARY AND CONCLUSIONS
We have used simultaneous AFM and confocal fluorescence
imaging of the cytoplasmic surface of membranes stripped
from both resting and activated RBL-2H3 cells to reveal the
presence of distinct membrane features (raised domains) that
have the ability to concentrate numerous membrane mole-
cules, including cross-linked receptors, gangliosides, and
clathrin. Raised domains are found in the membrane of both
resting and activated cells. The principal effect of cell acti-
vation is to cause the reorganization of membrane compo-
nents into larger domains. Based upon AFM measurements
of their thickness, lipid phase changes are unlikely to contrib-
ute substantially to these raised domains. We suggest instead
that they represent areas that concentrate transmembrane and
peripheral membrane proteins, either constitutively or indu-
cibly, and that their bulky cytoplasmic tails and associated
binding partners contribute to the height. Another significant
FIGURE 8 Distribution of PFO conjugated to 5 nm gold nanoparticles on
RBL cell membrane sheets seen by TEM. On sheets from control cells (A),
the abundant PFO label associates preferentially, but not exclusively, with
darkened membrane (arrow). After treatment with 10 mMMbCD (B), only a
few gold particles remain, demonstrating specificity of the PFO binding.
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contributor to the thickness may be clathrin lattices and
clusters of clathrin-coated pits.
Based on composition, we conclude that the raised do-
mains seen by AFM correspond to the dark patches observed
in TEM images of signaling domains that also localize the
immunoreceptor, FceRI, at least 10 associated signaling mole-
cules, and also molecules involved in coated pit assembly to
dark regions of activated mast cell membranes (16,17). Con-
centrated proteins could explain in part the increased amount
of carbon found by x-ray spectral imaging in the darkened
patches (2).
We showed by TEM that the cholesterol marker PFO
preferentially binds darkened membranes and by AFM that
cholesterol extraction by MbCD causes a large reduction in
height of the raised domains. These complementary results
indicate that cholesterol contributes significantly to the
formation or stability of the raised domains. The mechanism
is not known with certainty. It is possible that MbCD re-
duces domain height by extracting not only cholesterol but
also proteins in the form of protein-cholesterol complexes.
Another possibility is that the recruitment of signaling pro-
teins to the domains is reduced in the absence of cholesterol.
Additionally, we have observed by EM that the inner mem-
brane of MbCD-treated cells is enriched in flat clathrin arrays
but is totally lacking in coated vesicles (Fig. 7 D). If much
of the height is due to the curvature of 3-D clathrin lat-
tices, cholesterol extraction would appear to ‘‘flatten’’ those
structures.
The apparent relationship of the raised domains to the cyto-
skeleton (Fig. 10) is of particular interest. Previous fluores-
cence recovery after photobleaching data (38) and SPT data
(35,36) have led to models that consider roles for cytoskeletal
‘‘fences’’ or ‘‘corrals’’ and anchored protein ‘‘pickets’’ in the
temporary, dynamic confinement of membrane proteins and
lipids and also in the formation of less mobile macromolec-
ular complexes during signaling. In particular, the SPT studies
typically reveal free diffusion of proteins and lipids within
40–700 nm confinement zones accompanied by infrequent
intercompartmental transitions (‘‘anomalous diffusion’’,
‘‘hop diffusion’’). However, particularly for particles linked
FIGURE 10 (A and B) AFM topography of
RBL cell membrane sheets where cytoskeleton
cables (white arrows) appear to link numerous
raised domains. The maximum height in A is 54
nm and the maximum height in B is 45 nm. (C)
Cytoskeleton cable linkages (black arrows) ap-
pear in a TEM image.
FIGURE 9 Histogram display of distributions of
raised domain heights and widths as measured by cross
section (illustrated in Fig. 7). The data incorporate all the
membrane sheets in this study and were independent of
cell labeling by IgE, CTX-B, or clathrin. The clathrin
label (mouse monoclonal anti-clathrin heavy chain and
Alexa 488 F(ab9)2 goat anti-mouse IgG) adds;13 nm to
the domain height. Histogram A(C) shows the distribu-
tion of domain heights(widths) for activated (shaded
bars) and resting (open bars) membrane sheets. Histo-
gram B(D) is the distribution of heights(widths) for
membranes subjected to cholesterol extraction by
MbCD.
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to lipids, it has never been clear why interactions of the
cytoskeleton with components of the inner leaflet of the
membrane bilayer would regulate mobility in the outer leaflet
of the bilayer. The AFM images presented here show cyto-
skeletal elements surrounding and connecting the raised do-
mains. These images thus raise the possibility that the cortical
cytoskeleton may determine the stability and characteristics
of membrane domains, which in turn may determine the ability
of proteins (and lipids) to access and escape from these spe-
cialized regions.
In summary, AFM/fluorescence imaging of the inner
membrane landscape has revealed levels of topographical
complexity that are not addressed either in the well-mixed
lipid and protein model proposed by Singer and Nicholson
(1) or in progressively more complex models developed over
the subsequent decades that incorporate concepts of compo-
sitional and functional heterogeneity within the membrane
bilayer and between the membrane and the cytoskeleton
(34). Further analysis of the composition of distinct mem-
brane compartments across the topographic landscape is ex-
pected to reveal new insight into the relationship of membrane
geometry to membrane molecular organization and function.
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